WILMINGTON, Del., May 29, 2019 /PRNewswire/ -- James C. Collins, Jr., Chief Executive Officer-elect of Corteva Agriscience, Agriculture Division of DowDuPont (NYSE: DWDP), will present at Bernstein's 35th Annual Strategic Decisions Conference in New York, NY at 4:00 p.m. Eastern Time, on Thursday, May 30.
Collins will discuss the strategy for long-term shareholder value creation and growth, highlighting recent strategic achievements and progress toward the intended separation from DowDuPont.
In his presentation, Collins will also provide a detailed view of the dynamic U.S. market situation. Remarks will include an update on planting progress in the U.S. At this time, as a result of uncertainty in U.S. planting, the Agriculture Division cannot update full-year guidance for Corteva on a standalone basis. Presentation remarks will be followed by a moderated Q&A session.
DowDuPont invites investors to join a live webcast of the presentation through the DowDuPont website. A replay of this presentation and presentation materials will also be available on the website following the webcast.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Granular®, the newly launched Brevant™ seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience on Facebook, Instagram, LinkedIn, Twitter and YouTube.
About DowDuPont
DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow Chemical Company and DuPont with the intent to form strong, independent, publicly traded companies in agriculture, materials science and specialty products sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges. For more information, please visit us at www.dow-dupont.com.
All products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks or registered trademarks of DowDuPont.
View original content to download multimedia:http://www.prnewswire.com/news-releases/corteva-agriscience-agriculture-division-of-dowdupont-to-participate-in-bernsteins-35th-annual-strategic-decisions-conference-300858129.html
SOURCE DowDuPont
WILMINGTON, Del., May 29, 2019 /PRNewswire/ -- Ed Breen, Executive Chairman-elect of future DuPont, the premier innovation provider of value-added specialized solutions that transform industries and everyday lives, will present today at Bernstein's 35th Annual Strategic Decisions Conference at 9 a.m. ET in New York.
In his presentation, Breen will reaffirm financial guidance for the second quarter and full-year 2019 for the Specialty Products Division of DowDuPont ("DuPont"). Consistent with the guidance provided on May 2 with DowDuPont's first quarter results, the division reiterates second quarter guidance of down low-single digits for organic net sales and down low-single digits for adjusted operating EBITDA. For the full year, the division expects organic top line growth of 2 to 3 percent and 3 to 5 percent growth for adjusted operating EBITDA.
This morning DuPont also filed a Form 8-K with the U.S. Securities & Exchange Commission announcing non-cash, pre-tax charges in the approximate range of $800 million - $1,300 million in the second quarter 2019 primarily related to impairment testing of goodwill. The goodwill impairment is a result of revised financial projections of the current Industrial Biosciences reporting unit reflecting unfavorable market conditions, driven by slowed demand in the biomaterials business unit which is moving to the Non-Core segment effective June 1, 2019, and challenging conditions in U.S. bioethanol markets. The impairment does not impact DuPont's fiscal 2019 guidance.
DuPont invites investors to join a live webcast of the presentation through the DowDuPont website. A replay will also be available.
About DuPont, Specialty Products Division of DowDuPont
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, building and construction, health and wellness, food and worker safety. DowDuPont intends to separate its Agriculture Division through the intended pro rata distribution of the common stock of Corteva Inc. to its shareholders on June 1, 2019. DowDuPont will continue to hold the Specialty Products Division, as an independent, publicly traded company and change its registered name to DuPont de Nemours, Inc. which will be called DuPont. More information can be found at www.dow-dupont.com.
Cautionary Statement Regarding Forward Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the Corteva Distribution. Forward-looking statements, including those related to DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the Corteva Distribution, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which that are beyond DowDuPont's control. Some of the important factors that could cause DowDuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits from the Corteva Distribution and the April 1, 2019 distribution by DowDuPont of all of the shares of common stock of Dow Inc. on a pro rata basis to the holders of DowDuPont common stock (the "Dow Distribution"); (ii) restrictions under intellectual property cross license agreements entered into or to be entered into in connection with the Corteva Distribution and the Dow Distribution; (iii) ability to receive third-party consents required under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (iv) non-compete restrictions under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (v) the incurrence of significant costs in connection with the Corteva Distribution and the Dow Distribution, including increased costs from supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DowDuPont; (vi) risks outside the control of DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the Corteva Distribution, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and the requirement to redeem $12.7 billion of DowDuPont notes if the Corteva Distribution is abandoned or delayed beyond May 1, 2020; (vii) potential liability arising from fraudulent conveyance and similar laws in connection with the Corteva Distribution and/or the Dow Distribution; (viii) disruptions or business uncertainty, including from the Corteva Distribution, could adversely impact DowDuPont's business or financial performance and its ability to retain and hire key personnel; (ix) uncertainty as to the long-term value of DowDuPont common stock; (x) potential inability to access the capital markets; (xi) uncertainties related to share buybacks including board approval and costs, time and ability to complete; and (xii) risks to DowDuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's or Corteva's consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DowDuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of DowDuPont's 2018 Annual Report on Form 10-K as modified by DowDuPont's 2019 quarterly reports on Form 10-Q and current reports on Form 8-K.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dupont-to-present-at-bernsteins-35th-annual-strategic-decisions-conference-300858142.html
SOURCE DuPont
WILMINGTON, Del., May 21, 2019 /PRNewswire/ -- Ed Breen, executive chairman-elect of future DuPont, the premier innovation provider of value-added specialized solutions that transform industries and everyday lives, will present today at the 2019 Electrical Products Group (EPG) Conference at 10:45 a.m. ET in Coral Gables, FL.
In his presentation, Breen will reaffirm financial guidance for the second quarter and full-year 2019 for the Specialty Products Division of DowDuPont. Consistent with the guidance provided on May 2 with DowDuPont's first quarter results, the company reiterates second quarter guidance of down low-single digits for organic net sales and down low-single digits for adjusted operating EBITDA. For the full year, the division expects organic top line growth of 2 to 3 percent and 3 to 5 percent growth for adjusted operating EBITDA.
Breen will note that DuPont intends to announce a $2 billion share repurchase program, subject to Board of Director approval, shortly after its transition to an independent company upon the separation of its specialty products and agriculture businesses effective June 1, 2019. The company intends to make purchases under the plan during calendar 2019.
DuPont invites investors to join a live webcast of the presentation through the DowDuPont website. A replay will also be available.
About DuPont, Specialty Products Division of DowDuPont
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, building and construction, health and wellness, food and worker safety. DowDuPont intends to separate its Agriculture Division through the intended pro rata distribution of the common stock of Corteva Inc. to its shareholders on June 1, 2019. DowDuPont will continue to hold the Specialty Products Division, as an independent, publicly traded company and change its registered name to DuPont de Nemours, Inc. which will be called DuPont. More information can be found at www.dow-dupont.com.
Cautionary Statement Regarding Forward Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the Corteva Distribution. Forward-looking statements, including those related to DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the Corteva Distribution, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which that are beyond DowDuPont's control. Some of the important factors that could cause DowDuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits from the Corteva Distribution and the April 1, 2019 distribution by DowDuPont of all of the shares of common stock of Dow Inc. on a pro rata basis to the holders of DowDuPont common stock (the "Dow Distribution"); (ii) restrictions under intellectual property cross license agreements entered into or to be entered into in connection with the Corteva Distribution and the Dow Distribution; (iii) ability to receive third-party consents required under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (iv) non-compete restrictions under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (v) the incurrence of significant costs in connection with the Corteva Distribution and the Dow Distribution , including increased costs from supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DowDuPont; (vi) risks outside the control of DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the Corteva Distribution, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and the requirement to redeem $12.7 billion of DowDuPont notes if the Corteva Distribution is abandoned or delayed beyond May 1, 2020; (vii) potential liability arising from fraudulent conveyance and similar laws in connection with the Corteva Distribution and/or the Dow Distribution; (viii) disruptions or business uncertainty, including from the Corteva Distribution, could adversely impact DowDuPont's business or financial performance and its ability to retain and hire key personnel; (ix) uncertainty as to the long-term value of DowDuPont common stock; (x) potential inability to access the capital markets; (xi) uncertainties related to share buybacks including board approval and costs, time and ability to complete; and (xii) risks to DowDuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's or Corteva's consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DowDuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of DowDuPont's 2018 Annual Report on Form 10-K as modified by DowDuPont's 2019 quarterly reports on Form 10-Q and current reports on Form 8-K.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dupont-to-present-at-electrical-products-group-conference-300853587.html
SOURCE DuPont
WILMINGTON, Del., May 16, 2019 /PRNewswire/ -- DowDuPont announces that the board of directors of its subsidiary, E. I. du Pont de Nemours and Company, declared regular quarterly dividends of $1.12-1/2 per share on the $4.50 series preferred stock and $0.87-1/2 cents per share on the $3.50 series preferred stock of E. I. du Pont de Nemours and Company, both payable on July 25, 2019, to stockholders of record as shown on the books of E. I. du Pont de Nemours and Company at the close of business on July 10, 2019.
About DowDuPont
DowDuPont (NYSE: DWDP) is a holding company comprised of the future Corteva Agriscience™ and DuPont, which are expected to separate on June 1, 2019, creating two strong, independent, publicly traded companies in the agriculture and specialty products sectors, respectively. Each will lead their industry through productive, science-based innovation to meet the needs of customers and help solve global challenges. DowDuPont completed the separation of the materials science business through the spin-off of Dow Inc. (NYSE: Dow) on April 1, 2019. For more information, please visit us at www.dow-dupont.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-announces-declaration-of-regular-quarterly-dividend-on-e-i-du-pont-de-nemours-and-company-preferred-stock-300851604.html
SOURCE DowDuPont
WILMINGTON, Del., May 15, 2019 /PRNewswire/ -- DowDuPont (NYSE: DWDP) today announced that Nicholas C. (Nick) Fanandakis will retire as Executive Vice President effective July 31. Mr. Fanandakis is a 40-year DuPont veteran, who served as the company's CFO through 2017, when E.I. du Pont de Nemours and Company merged with The Dow Chemical Company. He continued to serve as CFO of the DuPont legal entity within DowDuPont until 2019. He has played a key role in the DowDuPont separation process into three companies, Dow (the former materials science division and now an independent company), Corteva Agriscience (the agriculture division) and DuPont (the specialty products division), which concludes on June 1.
DowDuPont CEO Ed Breen said, "On behalf of our Board of Directors and the entire company, I want to thank Nick for his great dedication and extraordinary service. Nick is responsible for countless achievements during his long career at DuPont, and he has shown tremendous leadership in the work we have done over the past three years to complete the DowDuPont merger and deliver on our plan to create three industry-leading, independent companies. We wish Nick and his family all the best in his well-earned retirement."
Mr. Fanandakis' career at DuPont began in 1979 in the Petrochemicals Department. In the years that followed, he served in a variety of positions across the company's divisions before taking on a series of key business leadership roles, focused primarily on the Industrial Solutions, Chemical and Applied Biosciences markets. Mr. Fanandakis became DuPont's CFO in 2009. He was instrumental in DuPont's transformation, overseeing the reshaping of the business portfolio, including the acquisition of Danisco, sale of the coatings business, and the spinoff of the chemical division. He also devoted considerable time and energy to developing and mentoring his team, many of whom are on the leadership teams of Dow, Corteva and DuPont.
About DowDuPont
DowDuPont (NYSE: DWDP) is a holding company comprised of the future Corteva Agriscience™ and DuPont, which are expected to separate on June 1, 2019, creating two strong, independent, publicly traded companies in the agriculture and specialty products sectors, respectively. Each will lead their industry through productive, science-based innovation to meet the needs of customers and help solve global challenges. DowDuPont completed the separation of the materials science business through the spin-off of Dow Inc. (NYSE: Dow) on April 1, 2019. For more information, please visit us at www.dow-dupont.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-announces-retirement-of-nicholas-fanandakis-300850667.html
SOURCE DowDuPont
WILMINGTON, Del., May 14, 2019 /PRNewswire/ -- DuPont today announced a new, comprehensive parental leave policy that offers four weeks of paid leave for new parents, including adoptive and same-sex parents. For birth mothers, the four paid weeks are in addition to an enhanced paid maternity leave which has been extended to 12 weeks. The new policy takes effect on June 1 in the United States and across all global locations no later than the end of 2020.
The policy applies new global minimum leave benefits, ensuring all employees receive at least these levels. Parents have the option of taking their four weeks of paid leave all at one time or intermittently during the first year. The policy also applies for each new child — not just the first.
"We are proud of our employees and when they become a new parent, we are excited to help them thrive at work and at home," said Marc Doyle, Chief Executive Officer-Elect for DuPont and Chief Operating Officer, DowDuPont Specialty Products Division. "Great companies care about their employees. This policy demonstrates that we care about our employees' well-being empowering them with the flexibility to make it easier to choose both family and career. What's more, it will enhance our ability to attract and retain top talent and lead to the continued success of our company as we transform our workplace."
About DowDuPont Specialty Products Division
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, building and construction, health and wellness, food and worker safety. DowDuPont intends to separate the Specialty Products Division, which will be called DuPont, into an independent, publicly traded company. More information can be found at www.dow-dupont.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dupont-enhances-global-parental-leave-policy-300849808.html
SOURCE DuPont
WILMINGTON, Del., May 14, 2019 /PRNewswire/ -- James C. Collins, Jr., Chief Executive Officer-elect of Corteva Agriscience, Agriculture Division of DowDuPont (NYSE: DWDP), will present at the BMO Capital Markets 14th Annual Farm to Market Conference in New York, NY at 3:30 p.m. Eastern Time, on Wednesday, May 15.
Collins will present recent progress on the business strategy and key priorities for shareholder value creation. Presentation remarks will also address financial performance on a division and standalone basis. Remarks will be followed by a moderated question and answer session.
DowDuPont invites investors to join a live webcast of the presentation through the DowDuPont website. A replay of this presentation will also be available on the website following the webcast.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Granular®, the newly launched Brevant™ seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience on Facebook, Instagram, LinkedIn, Twitter and YouTube.
About DowDuPont
DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow Chemical Company and DuPont with the intent to form strong, independent, publicly traded companies in agriculture, materials science and specialty products sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges. For more information, please visit us at www.dow-dupont.com.
® TM SM Trademarks and service marks of Dow AgroSciences, DuPont or Pioneer, and their affiliated companies or their respective owners.
View original content to download multimedia:http://www.prnewswire.com/news-releases/corteva-agriscience-agriculture-division-of-dowdupont-to-participate-in-bmo-capital-markets-farm-to-market-conference-300849323.html
SOURCE DowDuPont
WILMINGTON, Del., May 7, 2019 /PRNewswire/ -- Corteva, Inc. today announced that the U.S. Securities and Exchange Commission has declared effective Corteva's Registration Statement on Form 10. The Form 10 includes information regarding the business, strategy and priorities for Corteva, as well as details about the spin-off by DowDuPont Inc. of Corteva, which is expected to be completed on June 1, 2019. The Form 10 can be found on DowDuPont's website at http://www.dow-dupont.com/investors/default.aspx.
"This milestone marks the completion of all the regulatory requirements for us to separate into a leading pure-play independent agriculture company on June 1st. Corteva Agriscience is well positioned to drive long-term value for shareholders as we leverage our balanced portfolio and robust innovation pipeline to deliver the complete solution farmers need to maximize yield and profitability," said James C. Collins Jr., Corteva's Chief Executive Officer.
Earlier today, DowDuPont announced that its board of directors approved the spin-off of Corteva, declaring a pro rata dividend of all of the outstanding shares of common stock of Corteva. The dividend is expected to be paid on June 1, 2019 to DowDuPont stockholders of record as of the close of business on May 24, 2019, the record date. Effective as of the distribution date, each DowDuPont stockholder will receive one (1) share of Corteva common stock for every three (3) shares of DowDuPont common stock they held on the record date. Registered DowDuPont stockholders will receive cash in lieu of any fractional shares of Corteva common stock.
The New York Stock Exchange has authorized Corteva's common stock for listing and has advised that "when-issued" trading will begin on May 24, 2019, under the symbol "CTVA-WI." Following the spin-off, on June 3, 2019, Corteva common stock will begin "regular way" trading on the NYSE under the symbol "CTVA."
The spin-off is subject to the satisfaction or waiver of certain customary conditions, which are expected to be satisfied by the distribution date.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Granular®, the newly launched Brevant™ seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience on Facebook, Instagram, LinkedIn, Twitter and YouTube.
Cautionary Statement About Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended and Section 27A of the Securities Act of 1933, as amended, which may be identified by their use of words like "plans," "expects," "will," "anticipates," "believes," "intends," "projects," "estimates" or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva's strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, and financial results, as well as expected benefits from, the separation of Corteva from DowDuPont, are forward-looking statements.
Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond Corteva's control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Corteva's business, results of operations and financial condition. Some of the important factors that could cause Corteva's actual results to differ materially from those projected in any such forward-looking statements are: (i) effect of competition and consolidation in Corteva's industry; (ii) failure to successfully develop and commercialize Corteva's pipeline; (iii) failure to obtain or maintain the necessary regulatory approvals for some Corteva's products; (iv) failure to enforce Corteva's intellectual property rights or defend against intellectual property claims asserted by others; (v) effect of competition from manufacturers of generic products; (vi) costs of complying with evolving regulatory requirements; (vii) effect of the degree of public understanding and acceptance or perceived public acceptance of Corteva's biotechnology and other agricultural products; (viii) effect of changes in agricultural and related policies of governments and international organizations; (ix) impact of Corteva's dependence on its relationships or contracts with third parties; (x) effect of disruptions to Corteva's supply chain, information technology or network systems; (xi) effect of volatility in Corteva's input costs; and (xii) failure to realize the anticipated benefits of the series of internal reorganizations taken by DowDuPont in connection with the spin-off of Corteva, including failure to benefit from significant cost synergies.
Additionally, there may be other risks and uncertainties that Corteva is unable to currently identify or that Corteva does not currently expect to have a material impact on its business.
Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva's management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in Corteva's Registration Statement on Form 10 filed with the U.S. Securities and Exchange Commission.
View original content to download multimedia:http://www.prnewswire.com/news-releases/corteva-announces-effectiveness-of-form-10-registration-statement-300845686.html
SOURCE DowDuPont
WILMINGTON, Del., May 7, 2019 /PRNewswire/ -- DowDuPont (NYSE: DWDP) today announced that its Board of Directors has approved the previously announced separation of DowDuPont's Agriculture Division, which will become Corteva Agriscience™ on June 1, 2019. To effect the separation, the DowDuPont Board of Directors declared a pro rata dividend of all of the outstanding shares of common stock of Corteva, Inc. ("Corteva"). The dividend is expected to be paid on June 1, 2019 to DowDuPont stockholders of record as of the close of business on May 24, 2019, the record date. Effective as of the distribution date, each DowDuPont stockholder will receive one (1) share of Corteva common stock for every three (3) shares of DowDuPont common stock they held on the record date. Registered DowDuPont stockholders will receive cash in lieu of any fractional shares of Corteva common stock (the "Corteva Distribution").
Today, the company also announced that the U.S. Securities and Exchange Commission has declared effective the Registration Statement on Form 10 filed by Corteva. The Form 10 includes information regarding the business, strategy and priorities for Corteva. The Form 10 can be found on DowDuPont's website at http://www.dow-dupont.com/investors/default.aspx.
"Today's announcement marks a major milestone toward successfully separating Corteva on June 1," said Ed Breen, chief executive officer of DowDuPont. "We believe Corteva is set to be a leading pure-play agriculture company with a balanced portfolio and robust innovation pipeline that will drive long-term value for shareholders."
The New York Stock Exchange (the "NYSE") has authorized Corteva's common stock for listing and has advised that "when-issued" trading will begin on May 24, 2019 under the symbol "CTVA-WI." Following the spin-off, on June 3, 2019, Corteva common stock will begin "regular way" trading on the NYSE under the symbol "CTVA."
DowDuPont also provided additional information regarding its intended reverse stock split. As previously announced, the company is seeking stockholder approval at a special meeting on May 23, 2019 for a reverse stock split of its common stock at a ratio of not less than 2-for-5 and not greater than 1-for-3 (the "Reverse Stock Split"), with the specific ratio to be determined by the Board of Directors. DowDuPont announced today that if DowDuPont's stockholders approve the reverse stock split, the Board of Directors currently intends to select a reverse stock split ratio of one (1) new share of DowDuPont common stock for three (3) shares of current DowDuPont common stock and to implement the reverse stock split effective immediately following the Corteva Distribution. In connection with the Reverse Stock Split, it is expected that stockholders will receive cash in lieu of any fractional shares of DowDuPont common stock.
Beginning on May 24 and continuing through May 31, 2019, it is expected that there will be two markets in DowDuPont common stock on the NYSE: a "regular-way" market under the symbol "DWDP," in which DowDuPont shares will trade with the right to receive shares of Corteva common stock in the spin-off, and an "ex-distribution market" under the symbol "DD-WI," in which DowDuPont shares will trade without the right to receive shares of Corteva common stock in the spin-off. If you sell your DowDuPont shares in the "regular-way" market on or prior to the distribution date, you will be selling your right to receive Corteva common stock in the Corteva Distribution. If you buy DowDuPont shares in the "regular-way" market on or after the record date but on or prior to the distribution date, you are buying the right to receive Corteva common stock in the Corteva Distribution.
The price of shares of DowDuPont common stock traded in the "ex-distribution market" is expected to represent the right to a share of DowDuPont common stock following the Corteva Distribution, giving effect to the reduction of the number of outstanding shares of DowDuPont common stock as a result of the Reverse Stock Split (if approved by stockholders and implemented by the Board of Directors, which DowDuPont expects to be able to definitively announce on May 23, 2019). Investors are encouraged to consult with their financial advisors regarding the specific implication of buying or selling DowDuPont common stock on or before the distribution date.
No action is required by DowDuPont stockholders to receive shares of Corteva common stock in the Corteva Distribution. DowDuPont stockholders are encouraged to consult with their financial and tax advisors regarding the specific implications of the Corteva Distribution, including the specific implications of buying or selling DowDuPont common stock on or before the distribution date and the U.S. federal, state and local or foreign tax consequences, as applicable, of the Corteva Distribution.
DowDuPont previously announced that it intends to change its registered name from "DowDuPont Inc." to "DuPont de Nemours, Inc." doing business as "DuPont," on June 1, 2019. The company's common stock is expected to trade on the NYSE under the ticker symbol "DD" beginning on June 3, 2019.
The Corteva Distribution is subject to the satisfaction or waiver of certain customary conditions, which DowDuPont expects will be satisfied by the distribution date.
About DowDuPont
DowDuPont (NYSE: DWDP) is a holding company comprised of the future Corteva Agriscience™ and DuPont, which are expected to separate on June 1, 2019, creating two strong, independent, publicly traded companies in the agriculture and specialty products sectors, respectively. Each will lead their industry through productive, science-based innovation to meet the needs of customers and help solve global challenges. DowDuPont completed the separation of the Materials Science business through the spin-off of Dow Inc. (NYSE: Dow) on April 1, 2019. For more information, please visit us at www.dow-dupont.com.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Granular®, the newly launched Brevant™ seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Cautionary Statement Regarding Forward Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the Corteva Distribution. Forward-looking statements, including those related to DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the Corteva Distribution, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which that are beyond DowDuPont's control. Some of the important factors that could cause DowDuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits from the Corteva Distribution and the April 1, 2019 distribution by DowDuPont of all of the shares of common stock of Dow Inc. on a pro rata basis to the holders of DowDuPont common stock (the "Dow Distribution"); (ii) restrictions under intellectual property cross license agreements entered into or to be entered into in connection with the Corteva Distribution and the Dow Distribution; (iii) ability to receive third-party consents required under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (iv) non-compete restrictions under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (v) the incurrence of significant costs in connection with the Corteva Distribution and the Dow Distribution , including increased costs from supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DowDuPont; (vi) risks outside the control of DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the Corteva Distribution, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and the requirement to redeem $12.7 billion of DowDuPont notes if the Corteva Distribution is abandoned or delayed beyond May 1, 2020; (vii) potential liability arising from fraudulent conveyance and similar laws in connection with the Corteva Distribution and/or the Dow Distribution; (viii) disruptions or business uncertainty, including from the Corteva Distribution, could adversely impact DowDuPont's business or financial performance and its ability to retain and hire key personnel; (ix) uncertainty as to the long-term value of DowDuPont common stock; (x) potential inability to access the capital markets; and (xi) risks to DowDuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's or Corteva's consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DowDuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of DowDuPont's 2018 Annual Report on Form 10-K as modified by DowDuPont's 2019 quarterly reports on Form 10-Q and current reports on Form 8-K.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-board-of-directors-approves-corteva-distribution-and-announces-effectiveness-of-form-10-registration-statement-for-corteva-300845679.html
SOURCE DowDuPont
WILMINGTON, Del., May 2, 2019 /PRNewswire/ -- DuPont today announced that Raj Ratnakar has been named Chief Strategy Officer for the Specialty Products Division of DowDuPont, which is expected to become an independent company (the new DuPont) on June 1, 2019. Ratnakar's appointment is effective May 1. He will report to Marc Doyle, chief executive officer-elect for DuPont and chief operating officer, DowDuPont Specialty Products Division.
Ratnakar joins DuPont from Fortive, a $7 billion in annual revenue, publicly traded spin-off of Danaher, where he played a key role in designing and executing the separation. In this role, he also oversaw corporatewide strategic planning and led efforts to significantly transform the company's portfolio to build and shape Fortive into a high-performing, multi-industrial company. Ratnakar's previous experience includes senior strategy roles at both Danaher and TE Connectivity, as well as experience advising large corporate and private equity clients at McKinsey & Company.
"Active portfolio management and a disciplined approach to capital allocation are key drivers of DuPont's value creation strategy," said Doyle. "Raj's experience in leading efforts to create long-term portfolio strength, implementing global growth and profitability strategies and building organizational capabilities for continuous improvement and business transformation make him ideally suited to step into the corporate strategy role at DuPont. I look forward to working with him and the rest of the leadership team as we move rapidly toward becoming an independent company."
Ratnakar holds a master's degree in Mechanical Engineering from the University of Maryland, and an MBA with a major in Finance from The Wharton School at the University of Pennsylvania.
About DowDuPont Specialty Products Division
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, building and construction, health and wellness, food and worker safety. DowDuPont intends to separate the Specialty Products Division, which will be called DuPont, into an independent, publicly traded company. More information can be found at www.dow-dupont.com.
Cautionary Statement Regarding Forward Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the Corteva Distribution. Forward-looking statements, including those related to DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the Corteva Distribution, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which that are beyond DowDuPont's control. Some of the important factors that could cause DowDuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits from the Corteva Distribution and the April 1, 2019 distribution by DowDuPont of all of the shares of common stock of Dow Inc. on a pro rata basis to the holders of DowDuPont common stock (the "Dow Distribution"); (ii) restrictions under intellectual property cross license agreements entered into or to be entered into in connection with the Corteva Distribution and the Dow Distribution; (iii) ability to receive third-party consents required under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (iv) non-compete restrictions under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (v) the incurrence of significant costs in connection with the Corteva Distribution and the Dow Distribution , including increased costs from supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DowDuPont; (vi) risks outside the control of DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the Corteva Distribution, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and the requirement to redeem $12.7 billion of DowDuPont notes if the Corteva Distribution is abandoned or delayed beyond May 1, 2020; (vii) potential liability arising from fraudulent conveyance and similar laws in connection with the Corteva Distribution and/or the Dow Distribution; (viii) disruptions or business uncertainty, including from the Corteva Distribution, could adversely impact DowDuPont's business or financial performance and its ability to retain and hire key personnel; (ix) uncertainty as to the long-term value of DowDuPont common stock; (x) potential inability to access the capital markets; and (xi) risks to DowDuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's or Corteva, Inc.'s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DowDuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of DowDuPont's 2018 Annual Report on Form 10-K.
Divisional Disclaimer
Discussion of segment revenue and operating EBITDA on a divisional basis for Agriculture is based on the results of the Agriculture segment; for Materials Science is based on the combined results of the Performance Materials & Coatings, Industrial & Infrastructure, and Packaging & Specialty Plastics segments; and for Specialty Products is based on the combined results of the Electronics & Imaging, Nutrition & Biosciences, Transportation & Advanced Polymers, and Safety & Construction segments. The segment disclosures have been presented in this manner for informational purposes only and should not be viewed as an indication of the materials science division's current or future operating results on a standalone basis after the Dow Distribution or for agriculture and specialty products on a standalone basis assuming completion of the intended Corteva Distribution.
View original content to download multimedia:http://www.prnewswire.com/news-releases/raj-ratnakar-named-chief-strategy-officer-for-specialty-products-dupont-division-of-dowdupont-300842787.html
SOURCE DuPont
WILMINGTON, Del., May 2, 2019 /PRNewswire/ -- Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), will host an Investor Day on Thursday, May 9, 2019, in Johnston, Iowa.
During the event, Corteva Agriscience management will review progress on strategy and key priorities for shareholder value creation, providing an in-depth follow-up on recent product launches and expectations for regional growth. Management will also provide an update on standalone financials in preparation for the intended separation from DowDuPont.
Presentations will take place between 9:00 a.m. and 11:30 a.m. Eastern Time and will include remarks from James C. Collins, Jr., Chief Executive Officer-elect; Greg Friedman, Executive Vice President and Chief Financial Officer-elect; Rajan Gajaria, Executive Vice President, Business Platforms; Tim Glenn, Executive Vice President and Chief Commercial Officer; Neal Gutterson, Senior Vice President and Chief Technology Officer; Debra King, Senior Vice President and Chief Information Officer, and other members of the Corteva Agriscience senior leadership team.
The event will also include a tour of the onsite innovation facilities, spotlighting plant breeding, transgenic trait development, seed applied technology and digital capabilities.
Presentations will be webcast. Registration is available on the DowDuPont website – and a replay will be available on the website following the webcast.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Granular®, the newly launched Brevant™ seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience on Facebook, Instagram, LinkedIn, Twitter and YouTube.
About DowDuPont
DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow Chemical Company and DuPont with the intent to form strong, independent, publicly traded companies in agriculture, materials science and specialty products sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges. For more information, please visit us at www.dow-dupont.com.
® TM SM Trademarks and service marks of Dow AgroSciences, DuPont or Pioneer, and their affiliated companies or their respective owners.
Cautionary Statement About Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the separation of Corteva from DowDuPont. Forward-looking statements, including those related to the DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the separation of Corteva, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which are beyond Corteva's control. Some of the important factors that could cause actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits, including anticipated cost and growth synergies, from the separations of the agriculture business from DowDuPont, (ii) risks outside the control of Corteva and DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the intended separations of the agriculture business from DowDuPont, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, and other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated from DowDuPont, and changes in the regulatory or legal environment and requirement to redeem $12.7 billion of DowDuPont notes if such separations are abandoned or delayed beyond May 1, 2020; (iv) potential liability arising from fraudulent conveyance and similar laws in connection with the separations and distributions; (v) disruptions or business uncertainty, including from such separation, could adversely impact Corteva or DowDuPont's business (either directly or indirectly), or financial performance and its ability to retain and hire key personnel; (vi) uncertainty as to the long-term value of Corteva's common stock; (vii) potential inability to access the capital markets; and (viii) risks to Corteva's or DowDuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for Corteva or DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce Corteva's or DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U. S. Securities and Exchange Commission (the "Commission") as well as the preliminary registration statement on Form 10 of Corteva, in each case as may be amended from time to time in future filings with the Commission. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's or Corteva's consolidated financial condition, results of operations, credit rating or liquidity. Neither DowDuPont nor Corteva assumes any obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of the 2018 annual report on Form 10-K of DowDuPont and as set forth in the preliminary registration statement on Form 10 of Corteva, as may be amended from time to time in future filings with the Commission.
Non-GAAP Financial Measures
This communication includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. These measures include DowDuPont Agriculture Division's Operating EBITDA as adjusted to exclude currency, organic sales growth as well as an estimated full year operational tax rate for Corteva as a standalone company. DowDuPont and Corteva's management believes that these non-GAAP measures best reflect the ongoing performance of Corteva during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of Corteva and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. This data should be read in conjunction with Corteva's preliminary registration statement on Form 10, as amended from time to time. DowDuPont and Corteva do not provide forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because neither DowDuPont nor Corteva is able to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.
DowDuPont Ag Division's Operating EBITDA is defined as earnings (i.e., "Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses) excluding the impact of significant items. DowDuPont Ag Division's Operating EBITDA excluding currency is further adjusted to remove the impact of currency.
Organic sales and organic sales growth exclude the impact of foreign currency exchange rate fluctuation as well as acquisitions and divestitures.
The Full Year Operational tax rate for Corteva as a standalone company is defined as the effective income tax rate less the effect of exchange gains (losses), significant items, amortization expense associated with Historical DuPont's intangible assets and non-operating costs, net. Non-operating costs, net consists of non-operating pension and other post-employment benefit (OPEB) costs, environmental remediation and legal costs associated with legacy businesses and sites of Historical DuPont.
All products, unless otherwise noted, denoted with ™, SM or ® are trademarks or registered trademarks of DowDuPont.
View original content to download multimedia:http://www.prnewswire.com/news-releases/corteva-agriscience-agriculture-division-of-dowdupont-to-host-investor-day-300842384.html
SOURCE DowDuPont
WILMINGTON, Del., May 2, 2019 /PRNewswire/ --
First Quarter Financial Highlights
"Each business aggressively managed the levers within our control and benefitted from the strong foundations we have put in place in the face of discrete headwinds, including the effects of unprecedented bad weather, margin compression in key value chains, and sluggish auto and smartphone market conditions. Our emphasis on innovation and valued-added, higher margin products enabled us to benefit from stronger pricing in both our Specialty Products and Agriculture Divisions. We also advanced our cost synergies with an additional $400 million of savings in the quarter and we completed our $3 billion share repurchase program, repurchasing $1.6 billion in the quarter," said Ed Breen, chief executive officer of DowDuPont.
"In 30 days, we expect to complete our journey to create three leading companies in the materials science, agriculture and specialty products industries from the combination of two world-class organizations. I am confident that each of the companies we have created is a compelling investment opportunity in their respective space, with attractive financial characteristics and capital allocation policies, best-in-class cost structures and innovation priorities to accelerate growth. What we have accomplished would not have been possible without our highly talented and experienced leadership teams and their organizations. I want to thank each of my colleagues and wish them well as we move forward as new Dow, Corteva and new DuPont."
First Quarter Division Highlights
Materials Science
Performance Materials & Coatings
Performance Materials & Coatings net sales were $2.3 billion, down 2 percent versus the year-ago period. Volume increased 1 percent, with growth in Asia Pacific and EMEA, and price was flat with the year-ago period. Currency decreased sales by 3 percent.
Consumer Solutions sales were flat with the year-ago period as gains in volume and local price were offset by currency headwinds in EMEA and Asia Pacific. The business reported local price and volume increases in all regions for its differentiated silicones products. These gains were partially offset by year-over-year price declines in siloxanes intermediates.
Coatings & Performance Monomers reported a sales decline on lower volume, local price and currency, in part due to shedding of lower margin business and weather-related delays to seasonal demand in the U.S. & Canada and EMEA regions.
Operating EBITDA was $481 million, down 18 percent from operating EBITDA of $586 million in the year-ago period, primarily due to lower prices for siloxanes and shipping restrictions from a Performance Monomers facility in Deer Park, Texas, due to a fire at a nearby third-party storage and terminal facility.
Industrial Intermediates & Infrastructure
Industrial Intermediates & Infrastructure net sales were $3.4 billion, down 8 percent versus the year-ago period. Volume grew 6 percent, with gains in all regions. Local price declined 11 percent with decreases in all regions and both businesses. Currency decreased sales by 3 percent.
Polyurethanes & CAV sales declined, primarily driven by lower year-over-year isocyanates pricing, which were partially offset by higher volumes in all regions.
Industrial Solutions reported lower sales in all regions, driven by lower local price and currency headwinds in most regions. The business grew volume, driven by gains in EMEA and U.S. & Canada for industrial and oil and gas applications, as well as on strong demand for de-icing fluids, lubricants and fuels.
Equity affiliate losses for the segment were $48 million, compared with equity affiliate income of $149 million in the year-ago period. The year-over-year decline was driven by increased equity affiliate losses from the Sadara joint venture, driven by margin compression in isocyanates products, as well as lower margins for MEG produced by the Kuwait joint ventures.
Operating EBITDA was $448 million, down 31 percent from operating EBITDA of $654 million in the year-ago period. The decline in earnings was primarily due to lower equity affiliate income, as well as margin compression in isocyanates products.
Packaging & Specialty Plastics
Packaging & Specialty Plastics net sales were $5.1 billion, down 15 percent versus the year-ago period. Volume contracted 2 percent, driven primarily by higher ethane feedstock usage in the United States, which reduced sales of Hydrocarbons & Energy co-products. Local price declined 11 percent, driven by reduced polyethylene product prices and lower prices for Hydrocarbons & Energy co-products. Currency decreased sales 2 percent.
The Packaging and Specialty Plastics business grew volume on higher demand in Asia Pacific and EMEA, supported by new capacity adds. End-market growth was led by Industrial & Consumer Packaging and Flexible Food & Specialty Packaging.
Hydrocarbons & Energy volume declined, primarily due to increased ethylene integration from the startup of new downstream assets and higher ethane feedstock usage, which led to reduced co-product production.
Equity affiliate income was $38 million, compared with $59 million in the year-ago period. The decline was driven by lower earnings from the Kuwait joint ventures due to lower polyethylene pricing and increased turnaround costs.
Operating EBITDA was $993 million, down 24 percent from operating EBITDA of $1.3 billion in the year-ago period. Cost synergies, increased supply from growth projects and lower commissioning and startup costs were more than offset by margin compression across polyethylene products and reduced equity affiliate income.
Specialty Products
Electronics & Imaging
Electronics & Imaging reported net sales of $1.1 billion, down 7 percent from the year-ago period driven by volume and currency headwinds of 6 percent and 1 percent, respectively. Local price was flat with gains in the U.S. & Canada offset by declines in Asia Pacific and EMEA.
Organic sales growth in the U.S. & Canada and EMEA was more than offset by declines in Asia Pacific. Double-digit volume growth in Display Technologies was more than offset by declines in Interconnect Solutions and Photovoltaic and Advanced Materials. Soft smartphone demand, impacting both Interconnect Solutions and Semiconductor Technologies, and continued weakness in photovoltaics were the primary drivers of the volume decline.
Operating EBITDA for the segment was $385 million, a decrease of 3 percent from $398 million in the year-ago period. A gain on an asset sale and cost synergies were more than offset by higher unit cost, lower volumes and lower equity affiliate income.
Nutrition & Biosciences
Nutrition & Biosciences reported net sales of $1.7 billion, down 4 percent from the year-ago period. A 2 percent gain in local price was more than offset by headwinds from currency of 3 percent, volume of 2 percent and portfolio of 1 percent.
Volume gains in Nutrition & Health were more than offset by softer volumes in Industrial Biosciences. Nutrition & Health net volume gains were led by protein solutions and systems & texturants. Despite sequential growth from the fourth quarter 2018, probiotics realized a year-over-year volume decline due to higher than average sales in the first quarter of 2018. Industrial Biosciences volume declines were primarily the result of ongoing challenged conditions in U.S. energy markets negatively impacting demand in bioactives and microbial control.
Operating EBITDA for the segment was $390 million, down 7 percent from operating EBITDA of $418 million in the year-ago period on higher raw materials and a currency headwind, which more than offset cost synergy savings.
Transportation & Advanced Polymers
Transportation & Advanced Polymers reported net sales of $1.4 billion, down 5 percent from the year-ago period. Local price increases of 7 percent were more than offset by 9 percent lower volume and a 3 percent currency headwind.
Organic sales growth in the U.S. & Canada and EMEA was offset by declines in Asia Pacific. Local price increased 7 percent, mainly within Engineering Polymers, reflecting tight polymer supply and higher feedstock costs. Local price improved in all regions, led by Asia Pacific and EMEA.
Volume declined 9 percent due to lower autobuilds year-over-year, continued de-stocking in the channel, and weaker electronics demand. Volume was down in all regions except the U.S. & Canada.
Operating EBITDA for the segment totaled $414 million, a decrease of 5 percent from $437 million in the year-ago period. Higher local price and cost synergies were more than offset by higher raw material costs, lower volumes and currency headwinds.
Safety & Construction
Safety & Construction reported net sales of $1.3 billion, up 2 percent from the year-ago period. Organic sales increased 8 percent driven equally by local price gains and higher volumes. The December 1, 2018 divestiture of the European STYROFOAM™ business reduced sales by 4 percent and currency was a 2 percent headwind.
Volume gains of 4 percent were driven by continued strength across industrial, life & personal protection and medical end markets, resulting in strong growth in the Water Solutions business, Tyvek® protective garments and Kevlar® high-strength materials, more than offsetting continued softness in North America residential construction demand. Volume increased in all regions.
Local price improved 4 percent with gains in all regions and across all lines of business, led by strength in Kevlar® and Nomex® fibers.
Operating EBITDA for the segment totaled $411 million, an increase of 16 percent from $354 million in the year-ago period. Cost synergies, local price gains, and higher volume drove the improvement, which more than offset higher raw material costs and a currency headwind.
Agriculture
Sales in Crop Protection decreased 5 percent with increased price of 3 percent more than offset by 2 percent lower volume and currency headwinds of 6 percent. All regions outside North America delivered strong volume gains. Severe weather-related disruptions in North America drove an overall net volume decrease of 2 percent. Volume gains in EMEA, Latin America and Asia Pacific were driven by strength in the insecticide portfolio.
Sales in Seeds decreased 15 percent. Volume decreased 10 percent, primarily driven by weather in the corn belt, delaying seed deliveries into the second quarter. Volume in the U.S. & Canada was also impacted by early deliveries of seed in the fourth quarter of 2018. Volume increases in EMEA were largely driven by favorable weather leading to a strong corn season. Currency negatively impacted sales by 5 percent and pricing was about flat.
The Agriculture division confirms full year guidance of operating EBITDA of about $2.8 billion. Sales are expected to be flat with organic sales up low single digits percent. The division expects to overcome the first half decline through realization of price and volume opportunities on high demand products and new product launches and accelerated cost synergy delivery, resulting in an improvement in second half performance versus prior year.
Conference Call
The Company will host a live webcast of its first quarter earnings conference call with investors to discuss its results and business outlook today at 8:00 a.m. ET. The slide presentation that accompanies the conference call will be posted on the DowDuPont Investor Relations events and presentations page. A replay of the webcast will also be available on the investor events and presentations page of www.dow-dupont.com.
Dow will also hold a conference call for the first quarter of 2019, at 9 a.m. ET, to discuss the Materials Science Division's financial results within DowDuPont as well as Dow's outlook.
About DowDuPont™
DowDuPont (NYSE: DWDP) is a holding company comprised of the future Corteva Agriscience™ and DuPont, which are expected to separate on June 1, 2019, creating two strong, independent, publicly traded companies in the agriculture and specialty products sectors, respectively. Each will lead their industry through productive, science-based innovation to meet the needs of customers and help solve global challenges. DowDuPont completed the separation of the Materials Science business through the spin-off of Dow Inc. (NYSE: Dow) on April 1, 2019. For more information, please visit us at www.dow-dupont.com.
Contact Information: | |
DuPont | |
Investors: | Media: |
Lori Koch | Dan Turner |
+1 302-999-5631 | +1 302-996-8372 |
Dow | |
Investors: | Media: |
Neal Sheorey | Rachelle Schikorra |
+1 989-636-6347 | +1 989-638-4090 |
Corteva | |
Investors: | Media: |
Megan Britt | Gregg Schmidt |
+1 302-996-8881 | +1-302-996-8368 |
Cautionary Statement Regarding Forward Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the Corteva Distribution. Forward-looking statements, including those related to DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the Corteva Distribution, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which that are beyond DowDuPont's control. Some of the important factors that could cause DowDuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits from the Dow Distribution and the intended Corteva Distribution (ii) restrictions under intellectual property cross license agreements entered into or to be entered into in connection with the Corteva Distribution and the Dow Distribution; (iii) ability to receive third-party consents required under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (iv) non-compete restrictions under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (v) the incurrence of significant costs in connection with the Corteva Distribution and the Dow Distribution, including increased costs from supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DowDuPont; (vi) risks outside the control of DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the Corteva Distribution, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and the requirement to redeem $12.7 billion of DowDuPont notes if the Corteva Distribution is abandoned or delayed beyond May 1, 2020; (vii) potential liability arising from fraudulent conveyance and similar laws in connection with the Corteva Distribution and/or the Dow Distribution; (viii) disruptions or business uncertainty, including from the Corteva Distribution, could adversely impact DowDuPont's business or financial performance and its ability to retain and hire key personnel; (ix) uncertainty as to the long-term value of DowDuPont common stock; (x) potential inability to access the capital markets; and (xi) risks to DowDuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's or Corteva, Inc.'s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DowDuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of DowDuPont's 2018 Annual Report on Form 10-K.
Non-GAAP Financial Measures
This earnings release includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. DowDuPont's management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Non-GAAP measures included in this release are defined below. Reconciliations for these non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures starting on page 14. DowDuPont does not provide forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.
Adjusted earnings per share is defined as "Earnings per common share from continuing operations - diluted" excluding the after-tax impact of significant items and the after-tax impact of amortization expense associated with DuPont's intangible assets. Although amortization of DuPont's intangible assets is excluded from these non-GAAP measures, management believes it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in amortization of additional intangible assets.
Operating EBITDA is defined as earnings (i.e., "Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses), excluding the impact of significant items.
Organic Sales: Net Sales on an organic basis excludes impacts of currency and portfolio.
Discussion of segment revenue, operating EBITDA and price/volume metrics on a divisional basis for Agriculture is based on the results of the Agriculture segment; for Materials Science is based on the combined results of the Performance Materials & Coatings segment, the Industrial Intermediates & Infrastructure segment and the Packaging & Specialty Plastics segment; and for Specialty Products is based on the combined results of the Electronics & Imaging segment, the Nutrition & Biosciences segment, the Transportation & Advanced Polymers segment and the Safety & Construction segment. The Corporate segment is not included in the division metrics. The segment disclosures have been presented in this manner for informational purposes only and should not be viewed as an indication of each division's current or future operating results on a standalone basis assuming completion of the Intended Business Separations.
Trademarks
The Dow Diamond, DuPont Oval logo, DuPont™, the DowDuPont logo and all products, unless otherwise noted, denoted with ™, SM or ® are trademarks, service marks or registered trademarks of The Dow Chemical Company, E. I. du Pont de Nemours and Company, DowDuPont Inc. or their respective affiliates.
(1) Adjusted earnings per share and Operating EBITDA are non-GAAP measures. See page 8 for further discussion.
DowDuPont Inc. | ||||||
Consolidated Statements of Income | ||||||
In millions, except per share amounts (Unaudited) | Three Months Ended | |||||
Mar 31, | Mar 31, | |||||
Net sales | $ | 19,649 | $ | 21,510 | ||
Cost of sales | 14,726 | 16,315 | ||||
Research and development expenses | 717 | 768 | ||||
Selling, general and administrative expenses | 1,672 | 1,714 | ||||
Amortization of intangibles | 474 | 474 | ||||
Restructuring and asset related charges - net | 287 | 262 | ||||
Integration and separation costs | 813 | 457 | ||||
Equity in earnings of nonconsolidated affiliates | 26 | 257 | ||||
Sundry income (expense) - net | 248 | 115 | ||||
Interest expense and amortization of debt discount | 454 | 350 | ||||
Income from continuing operations before income taxes | 780 | 1,542 | ||||
Provision for income taxes on continuing operations | 209 | 389 | ||||
Income from continuing operations, net of tax | 571 | 1,153 | ||||
Loss from discontinued operations, net of tax | — | (5) | ||||
Net income | 571 | 1,148 | ||||
Net income attributable to noncontrolling interests | 51 | 44 | ||||
Net income available for DowDuPont Inc. common stockholders | $ | 520 | $ | 1,104 | ||
Per common share data: | ||||||
Earnings per common share from continuing operations - basic | $ | 0.23 | $ | 0.47 | ||
Loss per common share from discontinued operations - basic | — | — | ||||
Earnings per common share - basic | $ | 0.23 | $ | 0.47 | ||
Earnings per common share from continuing operations - diluted | $ | 0.23 | $ | 0.47 | ||
Loss per common share from discontinued operations - diluted | — | — | ||||
Earnings per common share - diluted | $ | 0.23 | $ | 0.47 | ||
Weighted-average common shares outstanding - basic | 2,250.1 | 2,317.0 | ||||
Weighted-average common shares outstanding - diluted | 2,259.2 | 2,334.3 |
DowDuPont Inc. | ||||||
Consolidated Balance Sheets | ||||||
In millions, except per share amounts (Unaudited) | Mar 31, | Dec 31, | ||||
Assets | ||||||
Current Assets | ||||||
Cash and cash equivalents (variable interest entities restricted - 2019: $109; 2018: $82) | $ | 11,543 | $ | 13,482 | ||
Marketable securities | 119 | 134 | ||||
Accounts and notes receivable: | ||||||
Trade (net of allowance for doubtful receivables - 2019: $204; 2018: $191) | 13,963 | 12,376 | ||||
Other | 4,783 | 4,963 | ||||
Inventories | 16,604 | 16,621 | ||||
Other current assets | 2,236 | 2,027 | ||||
Total current assets | 49,248 | 49,603 | ||||
Investments | ||||||
Investment in nonconsolidated affiliates | 4,687 | 5,204 | ||||
Other investments (investments carried at fair value - 2019: $1,797; 2018: $1,699) | 2,791 | 2,701 | ||||
Noncurrent receivables | 415 | 477 | ||||
Total investments | 7,893 | 8,382 | ||||
Property | ||||||
Property | 75,958 | 75,343 | ||||
Less accumulated depreciation | 40,383 | 39,495 | ||||
Net property (variable interest entities restricted - 2019: $718; 2018: $734) | 35,575 | 35,848 | ||||
Other Assets | ||||||
Goodwill | 58,948 | 59,032 | ||||
Other intangible assets (net of accumulated amortization - 2019: $7,865; 2018: $7,414) | 30,467 | 30,965 | ||||
Deferred income tax assets | 1,853 | 1,724 | ||||
Deferred charges and other assets | 5,801 | 2,476 | ||||
Total other assets | 97,069 | 94,197 | ||||
Total Assets | $ | 189,785 | $ | 188,030 | ||
Liabilities and Equity | ||||||
Current Liabilities | ||||||
Notes payable | $ | 2,995 | $ | 2,165 | ||
Long-term debt due within one year | 4,009 | 637 | ||||
Accounts payable: | ||||||
Trade | 8,333 | 9,457 | ||||
Other | 3,735 | 3,656 | ||||
Income taxes payable | 836 | 857 | ||||
Accrued and other current liabilities | 8,672 | 7,943 | ||||
Total current liabilities | 28,580 | 24,715 | ||||
Long-Term Debt (variable interest entities nonrecourse - 2019: $43; 2018: $75) | 34,966 | 37,662 | ||||
Other Noncurrent Liabilities | ||||||
Deferred income tax liabilities | 5,229 | 5,435 | ||||
Pension and other postretirement benefits - noncurrent | 15,626 | 15,909 | ||||
Asbestos-related liabilities - noncurrent | 1,133 | 1,142 | ||||
Other noncurrent obligations | 10,153 | 6,988 | ||||
Total other noncurrent liabilities | 32,141 | 29,474 | ||||
Stockholders' Equity | ||||||
Common stock (authorized 5,000,000,000 shares of $0.01 par value each; | 24 | 24 | ||||
Additional paid-in capital | 82,125 | 81,960 | ||||
Retained earnings | 29,764 | 30,536 | ||||
Accumulated other comprehensive loss | (12,364) | (12,394) | ||||
Unearned ESOP shares | (105) | (134) | ||||
Treasury stock at cost (2019: 112,316,990 shares; 2018: 83,452,554 shares) | (7,000) | (5,421) | ||||
DowDuPont's stockholders' equity | 92,444 | 94,571 | ||||
Noncontrolling interests | 1,654 | 1,608 | ||||
Total equity | 94,098 | 96,179 | ||||
Total Liabilities and Equity | $ | 189,785 | $ | 188,030 |
DowDuPont Inc. | ||||||
Net Sales by Segment and Geographic Region | ||||||
Net Sales by Segment and Geographic Region | Three Months Ended | |||||
In millions (Unaudited) | Mar 31, | Mar 31, | ||||
Agriculture | $ | 3,397 | $ | 3,808 | ||
Performance Materials & Coatings | 2,255 | 2,304 | ||||
Industrial Intermediates & Infrastructure | 3,402 | 3,715 | ||||
Packaging & Specialty Plastics | 5,110 | 6,010 | ||||
Electronics & Imaging | 1,078 | 1,153 | ||||
Nutrition & Biosciences | 1,659 | 1,720 | ||||
Transportation & Advanced Polymers | 1,355 | 1,425 | ||||
Safety & Construction | 1,322 | 1,299 | ||||
Corporate | 71 | 76 | ||||
Total | $ | 19,649 | $ | 21,510 | ||
U.S. & Canada | $ | 7,014 | $ | 7,909 | ||
EMEA 1 | 6,269 | 6,919 | ||||
Asia Pacific | 4,639 | 4,790 | ||||
Latin America | 1,727 | 1,892 | ||||
Total | $ | 19,649 | $ | 21,510 |
Net Sales Variance by Segment, Geographic Region and Division | Three Months Ended Mar 31, 2019 | ||||||||||
Local | Currency | Volume | Portfolio / Other | Total | |||||||
Percent change from prior year | |||||||||||
Agriculture | 1 | % | (5) | % | (7) | % | — | % | (11) | % | |
Performance Materials & Coatings | — | (3) | 1 | — | (2) | ||||||
Industrial Intermediates & Infrastructure | (11) | (3) | 6 | — | (8) | ||||||
Packaging & Specialty Plastics | (11) | (2) | (2) | — | (15) | ||||||
Electronics & Imaging | — | (1) | (6) | — | (7) | ||||||
Nutrition & Biosciences | 2 | (3) | (2) | (1) | (4) | ||||||
Transportation & Advanced Polymers | 7 | (3) | (9) | — | (5) | ||||||
Safety & Construction | 4 | (2) | 4 | (4) | 2 | ||||||
Total | (4) | % | (3) | % | (2) | % | — | % | (9) | % | |
U.S. & Canada | (4) | % | — | % | (7) | % | — | % | (11) | % | |
EMEA 1 | (3) | (6) | 1 | (1) | (9) | ||||||
Asia Pacific | (4) | (2) | 3 | — | (3) | ||||||
Latin America | (6) | (2) | (1) | — | (9) | ||||||
Total | (4) | % | (3) | % | (2) | % | — | % | (9) | % | |
Agriculture | 1 | % | (5) | % | (7) | % | — | % | (11) | % | |
Materials Science | (9) | (2) | 1 | — | (10) | ||||||
Specialty Products | 3 | (2) | (3) | (1) | (3) | ||||||
Total | (4) | % | (3) | % | (2) | % | — | % | (9) | % |
1. | Europe, Middle East and Africa. |
DowDuPont Inc. | ||||||
Selected Financial Information and Non-GAAP Measures | ||||||
Operating EBITDA by Segment 1 | Three Months Ended | |||||
In millions (Unaudited) | Mar 31, | Mar 31, | ||||
Agriculture | $ | 667 | $ | 891 | ||
Performance Materials & Coatings | 481 | 586 | ||||
Industrial Intermediates & Infrastructure | 448 | 654 | ||||
Packaging & Specialty Plastics | 993 | 1,301 | ||||
Electronics & Imaging | 385 | 398 | ||||
Nutrition & Biosciences | 390 | 418 | ||||
Transportation & Advanced Polymers | 414 | 437 | ||||
Safety & Construction | 411 | 354 | ||||
Corporate | (170) | (168) | ||||
Total | $ | 4,019 | $ | 4,871 | ||
Equity in Earnings (Losses) of Nonconsolidated Affiliates by Segment 2 | Three Months Ended | |||||
In millions (Unaudited) | Mar 31, | Mar 31, | ||||
Agriculture | $ | — | $ | (1) | ||
Performance Materials & Coatings | — | — | ||||
Industrial Intermediates & Infrastructure | (48) | 149 | ||||
Packaging & Specialty Plastics | 38 | 59 | ||||
Electronics & Imaging | 29 | 48 | ||||
Nutrition & Biosciences | 4 | 3 | ||||
Transportation & Advanced Polymers | 2 | 3 | ||||
Safety & Construction | 7 | 5 | ||||
Corporate | (6) | (9) | ||||
Total | $ | 26 | $ | 257 | ||
Reconciliation of "Income from continuing operations, net of tax" to "Operating EBITDA" | Three Months Ended | |||||
In millions (Unaudited) | Mar 31, | Mar 31, | ||||
Income from continuing operations, net of tax | $ | 571 | $ | 1,153 | ||
+ Provision for income taxes on continuing operations | 209 | 389 | ||||
Income from continuing operations before income taxes | $ | 780 | $ | 1,542 | ||
+ Depreciation and amortization | 1,519 | 1,484 | ||||
- Interest income 3 | 75 | 55 | ||||
+ Interest expense and amortization of debt discount | 454 | 350 | ||||
- Foreign exchange gains (losses), net 3, 4 | (11) | (98) | ||||
- Significant items | (1,330) | (1,452) | ||||
Operating EBITDA 1 | $ | 4,019 | $ | 4,871 |
1. | The Company uses Operating EBITDA as its measure of profit/loss for segment reporting. The Company defines Operating EBITDA as earnings (i.e., "Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses), excluding the impact of significant items. |
2. | Does not exclude the impact of significant items. |
3. | Included in "Sundry income (expense) - net." |
4. | Excludes a $50 million pretax foreign exchange loss significant item related to adjustments to foreign currency exchange contracts for the change in the U.S. tax rate during 2018. |
DowDuPont Inc. Selected Financial Information and Non-GAAP Measures | ||||||||||
Significant Items Impacting Results for the Three Months Ended Mar 31, 2019 | ||||||||||
In millions, except per share amounts (Unaudited) | Pretax 1 | Net Income 2 | EPS 3 | Income Statement Classification | ||||||
Reported results | $ | 780 | $ | 520 | $ | 0.23 | ||||
Less: Significant items | ||||||||||
Inventory step-up amortization | (205) | (171) | (0.08) | Cost of sales | ||||||
Integration and separation costs | (813) | (670) | (0.30) | Integration and separation costs; Provision | ||||||
Restructuring and asset related charges - net | (288) | (252) | (0.11) | Restructuring and asset related charges - net | ||||||
Loss on divestiture 4 | (24) | (24) | (0.01) | Sundry income (expense) - net | ||||||
Total significant items | $ | (1,330) | $ | (1,117) | $ | (0.50) | ||||
Less: DuPont amortization of intangibles | (320) | (253) | (0.11) | Amortization of intangibles | ||||||
Adjusted results (non-GAAP) | $ | 2,430 | $ | 1,890 | $ | 0.84 | ||||
Significant Items Impacting Results for the Three Months Ended Mar 31, 2018 | ||||||||||
In millions, except per share amounts (Unaudited) | Pretax 1 | Net Income 2 | EPS 3 | Income Statement Classification | ||||||
Reported results | $ | 1,542 | $ | 1,109 | $ | 0.47 | ||||
Less: Significant items | ||||||||||
Inventory step-up amortization | (703) | (618) | (0.26) | Cost of sales | ||||||
Integration and separation costs | (457) | (356) | (0.15) | Integration and separation costs | ||||||
Restructuring and asset related charges - net | (262) | (205) | (0.09) | Restructuring and asset related charges - net | ||||||
Gain on the sale of business/entity 5 | 20 | 15 | 0.01 | Sundry income (expense) - net | ||||||
Income tax related items 6 | (50) | (109) | (0.05) | Sundry income (expense) - net ($50 million); Provision for income taxes on continuing | ||||||
Total significant items | $ | (1,452) | $ | (1,273) | $ | (0.54) | ||||
Less: DuPont amortization of intangibles | (315) | (249) | (0.11) | Amortization of intangibles | ||||||
Adjusted results (non-GAAP) | $ | 3,309 | $ | 2,631 | $ | 1.12 |
1. | "Income from continuing operations before income taxes." |
2. | "Net income available for DowDuPont Inc. common stockholders" excluding the impact of discontinued operations. The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |
3. | "Earnings per common share from continuing operations - diluted." |
4. | Reflects a $24 million loss related to Historical Dow's sale of a joint venture related to synergy actions. |
5. | Reflects a $20 million pretax gain related to Historical Dow's sale of its equity interest in MEGlobal. |
6. | Related to effects of U.S. Tax Reform. Impacts include a $50 million pretax foreign exchange loss ($38 million after-tax) related to adjustments to foreign currency exchange contracts for the change in the U.S. tax rate. |
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-reports-first-quarter-2019-results-300842368.html
SOURCE DowDuPont
WILMINGTON, Del., April 29, 2019 /PRNewswire/ -- DowDuPont™ (NYSE: DWDP) announced on March 8, 2019, that it declared a dividend of $325 million in the aggregate payable May 28, 2019, on a pro rata basis to shareholders of record on April 26, 2019. Based on the number of shares outstanding as of the record date, the per share amount of the dividend to be paid on May 28, 2019 is $0.14.
About DowDuPont Inc.
DowDuPont is a holding company with the intent to form strong, independent, publicly traded companies in agriculture and specialty products sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges. For more information, please visit us at www.dow-dupont.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-provides-per-share-information-for-its-second-quarter-dividend-300840071.html
SOURCE DowDuPont
WILMINGTON, Del., April 18, 2019 /PRNewswire/ -- DowDuPont™ (NYSE: DWDP) is providing expected divisional results for the first quarter of 2019.
The company expects to report total company results in line with the guidance provided on March 28 and is now providing additional detail regarding expected results at the division level: Specialty Products anticipates reporting better than expected results; Materials Science results are expected to be in line with its updated guidance; and Agriculture is expected to report results that are lower than its updated guidance, due to the longer than expected impact of severe weather-related conditions.
The division expects to record net sales of $3.4 billion and operating EBITDA of about $665 million, down 11 and 25 percent versus the same quarter last year, respectively. For the first half of 2019, the division anticipates net sales to be down low-single digits percent and operating EBITDA to be 3 to 5 percent below the same period last year. Deliveries are on track with current expectations and the revised first half guidance reflects the possibility of reduced planted acres overall, lower than anticipated corn acres, and continued delays to the start of the planting season due to additional weather events.
The division confirms full year guidance of organic sales up low-single digits percent and operating EBITDA of about $2.8 billion. The division expects to overcome the first half decline through realization of price and volume opportunities on high demand products and new product launches and accelerated cost synergy delivery, resulting in an improvement in second half performance versus prior year.
DowDuPont will release its full financial results for the first quarter of 2019 on May 2. Analysts are encouraged to join the Company's earnings conference call at 8 a.m. ET. DowDuPont will release its first quarter earnings results via press release prior to the call. Dow will also hold a conference call for the first quarter of 2019, at 9 a.m. ET, to discuss the Materials Science Division's financial results within DowDuPont as well as Dow's outlook.
About DowDuPont
DowDuPont (NYSE: DWDP) is a holding company comprised of the future Corteva Agriscience™ and DuPont, which are expected to separate on June 1, 2019, creating two strong, independent, publicly traded companies in the agriculture and specialty products sectors, respectively. Each will lead their industry through productive, science-based innovation to meet the needs of customers and help solve global challenges. DowDuPont completed the separation of the materials science business through the spin-off of Dow Inc. (NYSE: Dow) on April 1, 2019. For more information, please visit us at www.dow-dupont.com.
Cautionary Statement Regarding Forward Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the Corteva Distribution. Forward-looking statements, including those related to DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the Corteva Distribution, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which that are beyond DowDuPont's control. Some of the important factors that could cause DowDuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits from the Corteva Distribution and the April 1, 2019 distribution by DowDuPont of all of the shares of common stock of Dow Inc. on a pro rata basis to the holders of DowDuPont common stock (the "Dow Distribution"); (ii) restrictions under intellectual property cross license agreements entered into or to be entered into in connection with the Corteva Distribution and the Dow Distribution; (iii) ability to receive third-party consents required under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (iv) non-compete restrictions under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (v) the incurrence of significant costs in connection with the Corteva Distribution and the Dow Distribution , including increased costs from supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DowDuPont; (vi) risks outside the control of DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the Corteva Distribution, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and the requirement to redeem $12.7 billion of DowDuPont notes if the Corteva Distribution is abandoned or delayed beyond May 1, 2020; (vii) potential liability arising from fraudulent conveyance and similar laws in connection with the Corteva Distribution and/or the Dow Distribution; (viii) disruptions or business uncertainty, including from the Corteva Distribution, could adversely impact DowDuPont's business or financial performance and its ability to retain and hire key personnel; (ix) uncertainty as to the long-term value of DowDuPont common stock; (x) potential inability to access the capital markets; and (xi) risks to DowDuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's or Corteva, Inc.'s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DowDuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of DowDuPont's 2018 Annual Report on Form 10-K.
Divisional Disclaimer
Discussion of segment revenue and operating EBITDA on a divisional basis for Agriculture is based on the results of the Agriculture segment; for Materials Science is based on the combined results of the Performance Materials & Coatings, Industrial & Infrastructure, and Packaging & Specialty Plastics segments; and for Specialty Products is based on the combined results of the Electronics & Imaging, Nutrition & Biosciences, Transportation & Advanced Polymers, and Safety & Construction segments. The segment disclosures have been presented in this manner for informational purposes only and should not be viewed as an indication of the materials science division's current or future operating results on a standalone basis after the Dow Distribution or for agriculture and specialty products on a standalone basis assuming completion of the intended Corteva Distribution.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-provides-update-regarding-first-quarter-2019-performance-300834426.html
SOURCE DowDuPont
WILMINGTON, Del., April 17, 2019 /PRNewswire/ -- DowDuPont (NYSE: DWDP) today announced three additional members to the future board of directors of DuPont, currently the Specialty Products Division of DowDuPont. The new directors include Frank K. Clyburn, chief commercial officer at Merck & Co., Inc., Terrence R. Curtin, CEO of TE Connectivity, and Frederick M. Lowery, senior vice president and president, Life Sciences Solutions and Laboratory Products at Thermo Fisher Scientific Inc. With these additions, DuPont expects to have 12 members on its board, effective June 1, 2019.
Ed Breen, executive chairman-elect of DuPont and current Chair and CEO of DowDuPont, said, "DuPont's board of directors is composed of highly qualified leaders, with the right mix of skills and experience to position the independent company to drive sustainable growth. The new directors bring deep global expertise in electronics and pharmaceuticals, as well as manufacturing, further strengthening the overall board, which will work closely with the management team to oversee the successful execution of DuPont's strategy and enhance value for shareholders."
"We're excited to welcome Frank Clyburn, Terrence Curtin, and Fred Lowery to the future DuPont board," said Marc Doyle, CEO-elect of DuPont. "Their diverse perspectives and expertise will be invaluable as we leverage our proprietary technology and deep customer relationships to drive innovation in attractive high-growth markets."
DowDuPont remains on track to separate the Agriculture Division (Corteva Agriscience™) and Specialty Products Division (DuPont) on June 1, 2019.
In addition to Mr. Clyburn, Mr. Curtin, and Mr. Lowery, DuPont's future board of directors includes: Edward D. Breen, CEO of DowDuPont and executive chairman-elect of DuPont; Ruby R. Chandy, former president of Industrial Division of Pall Corp.; Alexander M. Cutler, lead independent director of DowDuPont and former chairman and chief executive officer of Eaton; Marc Doyle, COO of the Specialty Products Division of DowDuPont and CEO-elect of DuPont; Eleuthère I. du Pont, former president and chief financial officer of Wawa and president of The Longwood Foundation; Rajiv L. Gupta, chairman of APTIV PLC (formerly Delphi Automotive PLC) and former chairman and CEO of Rohm & Haas; Luther C. Kissam, IV, chairman, president and CEO of Albemarle Corporation; Raymond J. Milchovich, former chairman and CEO of Foster Wheeler AG; and Steven Sterin, former executive vice president, CFO of Andeavor and former president of Andeavor Logistics.
Biographies of New Directors
Frank K. Clyburn is Chief Commercial Officer at Merck, a publicly traded global pharmaceutical company. He became CCO in 2019 and is responsible for operations and P&L across Merck's human health commercial portfolio globally. He previously held various senior leadership positions within the company, most recently serving as President of Global Oncology from 2013 to 2018. He joined Merck in 2008 following eight years as Vice President of various business units at Sanofi-Aventis S.A. (now Sanofi). Earlier in his career, Mr. Clyburn served in a wide range of commercial roles of increasing responsibility at Hoechst Marion Roussel Inc. (now part of Sanofi) from 1994 to 2000. He started his career at Marion Merrell Dow Inc. from1987 to 1994.
Terrence R. Curtin is the CEO of TE Connectivity, a publicly traded global leader in connectivity and sensor solutions. Prior to assuming the role of CEO in 2017, Mr. Curtin served as TE's President, where he was responsible for all of the company's businesses and mergers and acquisition activities. He joined TE Connectivity in 2001 and has held various senior positions within the company, including as Chief Financial Officer. Prior to TE Connectivity, Mr. Curtin had positions of increasing responsibility at Arthur Andersen LLP from 1990 to 2001. Mr. Curtin has served as a director of the board of TE Connectivity since 2016.
Frederick "Fred" M. Lowery is Senior Vice President and President, Life Sciences Solutions and Laboratory Products at Thermo Fisher Scientific Inc., a publicly traded provider of products and services for life sciences, healthcare and applied markets. In this role, he leads the BioProduction, Laboratory Products and Laboratory Chemicals businesses, as well as several functions within Life Sciences Solutions. Since joining Thermo Fisher in 2005, he has held a number of senior leadership positions across businesses. Prior to his time at Thermo Fisher, Mr. Lowery was with Maytag Corporation from 1999 to 2005. He began his career as an engineer at General Motors Company, where he worked from 1994 to 1999.
About DowDuPont Inc.
DowDuPont is a holding company with the intent to form strong, independent, publicly traded companies in agriculture and specialty products sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges. For more information, please visit us at www.dow-dupont.com.
About DuPont, Specialty Products Division of DowDuPont
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, building and construction, health and wellness, food and worker safety. DowDuPont intends to separate the Specialty Products Division, which will be called DuPont, into an independent, publicly traded company. More information can be found at www.dow-dupont.com.
Cautionary Statement Regarding Forward Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the Corteva Distribution. Forward-looking statements, including those related to DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the Corteva Distribution, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which that are beyond DowDuPont's control. Some of the important factors that could cause DowDuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits from the Corteva Distribution and the April 1, 2019 distribution by DowDuPont of all of the shares of common stock of Dow Inc. on a pro rata basis to the holders of DowDuPont common stock (the "Dow Distribution"); (ii) restrictions under intellectual property cross license agreements entered into or to be entered into in connection with the Corteva Distribution and the Dow Distribution; (iii) ability to receive third-party consents required under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (iv) non-compete restrictions under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (v) the incurrence of significant costs in connection with the Corteva Distribution and the Dow Distribution , including increased costs from supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DowDuPont; (vi) risks outside the control of DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the Corteva Distribution, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and the requirement to redeem $12.7 billion of DowDuPont notes if the Corteva Distribution is abandoned or delayed beyond May 1, 2020; (vii) potential liability arising from fraudulent conveyance and similar laws in connection with the Corteva Distribution and/or the Dow Distribution; (viii) disruptions or business uncertainty, including from the Corteva Distribution, could adversely impact DowDuPont's business or financial performance and its ability to retain and hire key personnel; (ix) uncertainty as to the long-term value of DowDuPont common stock; (x) potential inability to access the capital markets; and (xi) risks to DowDuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's or Corteva, Inc.'s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DowDuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of DowDuPont's 2018 Annual Report on Form 10-K.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-announces-new-members-for-future-board-of-directors-of-dupont-300833455.html
SOURCE DowDuPont
WILMINGTON, Del., April 3, 2019 /PRNewswire/ -- DowDuPont Inc. (NYSE: DWDP) announced today that its Board of Directors has approved a reverse stock split of the Company's common stock. The reverse stock split is intended to increase the market price of DowDuPont's common stock in connection with the Company's intended distribution of all of the shares of common stock of its wholly owned subsidiary, Corteva Inc., which holds the Company's Agriculture Business, to the holders of the Company's common stock on a pro rata basis (the "Corteva Distribution"). The reverse stock split is subject to stockholder approval. If approved, the Company expects to implement the reverse stock split effective immediately following the Corteva Distribution.
The Company plans to hold a Special Meeting of Stockholders, at which stockholders are being asked to vote on a proposal to adopt and approve the reverse stock split, at 9:00 am local time, on May 23, 2019, at 974 Centre Road, Chestnut Run Plaza, Building 730 in Wilmington, Delaware. DowDuPont's Board has set May 1, 2019 as the record date for stockholders entitled to vote at the special meeting.
If stockholders approve the reverse stock split, the Board of Directors will select a reverse stock split ratio of not less than 2-for-5 and not greater than 1-for-3, with an exact ratio as may be determined by the Board of Directors at a later date so that, depending on the ratio chosen, stockholders' shares of issued and outstanding common stock will be converted at a ratio between (i) two shares of issued and outstanding common stock for every five shares of common stock owned and (ii) one share of issued and outstanding common stock for every three shares of common stock owned. The price of each common share is expected to increase so that a stockholder would have fewer but higher priced shares. A reverse stock split would not have any impact on the voting and other rights of stockholders, and will have no impact on the Company's business operations or any of its outstanding indebtedness.
Even if the reverse stock split is approved by the Company's stockholders, the Board of Directors may delay or abandon the reverse stock split at any time prior to the effective time of the reverse stock split if the Board of Directors determines that the reverse stock split is no longer in the best interests of the Company or its stockholders.
DowDuPont will file a preliminary proxy statement related to the special meeting later today. The Company expects to file and mail its definitive proxy material in due course. DowDuPont encourages stockholders to read the proxy statement and other material relating to the special meeting, as it contains important information. Stockholders may obtain a free copy of the proxy statement and other documents that the company files with the SEC at the SEC's website at www.sec.gov, or from the company by directing a request to DowDuPont Inc., 974 Centre Road, Wilmington, Delaware 19805, Attention: Investor Relations, or at www.dow-dupont.com.
About DowDuPont Inc.
DowDuPont (NYSE: DWDP) is a holding company with the intent to form strong, independent, publicly traded companies in agriculture (Corteva Agriscence™) and specialty products (DuPont) sectors. Upon completion of the intended separation of Corteva Agriscence™, the companies will lead their respective industries by delivering differentiated products and solutions and science-based innovation to meet the needs of customers and help solve global challenges. For more information, please visit us at www.dow-dupont.com.
Cautionary Statement Regarding Forward Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the Corteva Distribution. Forward-looking statements, including those related to DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the Corteva Distribution, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which that are beyond DowDuPont's control. Some of the important factors that could cause DowDuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits from the Corteva Distribution and the April 1, 2019 distribution by DowDuPont of all of the shares of common stock of Dow Inc. on a pro rata basis to the holders of DowDuPont common stock (the "Dow Distribution"); (ii) restrictions under intellectual property cross license agreements entered into or to be entered into in connection with the Corteva Distribution and the Dow Distribution; (iii) ability to receive third-party consents required under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (iv) non-compete restrictions under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (v) the incurrence of significant costs in connection with the Corteva Distribution and the Dow Distribution , including increased costs from supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DowDuPont; (vi) risks outside the control of DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the Corteva Distribution, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and the requirement to redeem $12.7 billion of DowDuPont notes if the Corteva Distribution is abandoned or delayed beyond May 1, 2020; (vii) potential liability arising from fraudulent conveyance and similar laws in connection with the Corteva Distribution and/or the Dow Distribution; (viii) disruptions or business uncertainty, including from the Corteva Distribution, could adversely impact DowDuPont's business or financial performance and its ability to retain and hire key personnel; (ix) uncertainty as to the long-term value of DowDuPont common stock; (x) potential inability to access the capital markets; and (xi) risks to DowDuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's or Corteva, Inc.'s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DowDuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of DowDuPont's 2018 Annual Report on Form 10-K.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-announces-plans-for-reverse-stock-split-300824190.html
SOURCE DowDuPont
WILMINGTON, Del., April 1, 2019 /PRNewswire/ -- DowDuPont Inc. (NYSE: DWDP) today announced that it has completed the separation of its Materials Science Division through the spin-off of Dow Inc. ("Dow"). Dow begins "regular way" trading tomorrow on the NYSE under the symbol "DOW." DowDuPont common stockholders received one share of common stock of Dow for every three shares of DowDuPont common stock they held as of the close of business on March 21, 2019. DowDuPont common stockholders will also receive cash in lieu of fractional shares of Dow common stock.
"Today's announcement completes our first step toward creating three strong, independent growth companies set to be industry leaders focused on driving innovation and delivering long-term value for shareholders," said Ed Breen, chief executive officer of DowDuPont. "Dow begins its next chapter as a more focused, disciplined and market-oriented company, and I am excited for the tremendous opportunities ahead for its employees, shareholders, and customers."
DowDuPont remains on track to complete the previously announced separation of its Agriculture Division (Corteva Agriscience™) on June 1, 2019 through the intended distribution of all of the shares of common stock of its wholly owned subsidiary, Corteva, Inc., which holds the Company's Agriculture Division, to the holders of the Company's common stock on a pro rata basis (the "Corteva Distribution"). Subsequent to the Corteva Distribution, DowDuPont would hold the Specialty Products Division and be renamed "DuPont."
About DowDuPont Inc.
DowDuPont (NYSE: DWDP) is a holding company with the intent to form strong, independent, publicly traded companies in agriculture (Corteva Agriscence™) and specialty products (DuPont) sectors. Upon completion of the intended separation of Corteva Agriscence™, the companies will lead their respective industries by delivering differentiated products and solutions and science-based innovation to meet the needs of customers and help solve global challenges. For more information, please visit us at www.dow-dupont.com.
Cautionary Statement Regarding Forward Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the Corteva Distribution. Forward-looking statements, including those related to DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the Corteva Distribution, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which that are beyond DowDuPont's control. Some of the important factors that could cause DowDuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits from the Corteva Distribution and the April 1, 2019 distribution by DowDuPont of all of the shares of common stock of Dow Inc. on a pro rata basis to the holders of DowDuPont common stock (the "Dow Distribution"); (ii) restrictions under intellectual cross property agreements entered into or to be entered into in connection with the Corteva Distribution and the Dow Distribution; (iii) ability to receive third-party consents required under the separation agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (iv) non-compete restrictions under the separation agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (v) the incurrence of significant costs in connection with the Corteva Distribution and the Dow Distribution, including increased costs from supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DowDuPont; (vi) risks outside the control of DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the Corteva Distribution, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and the requirement to redeem $12.7 billion of DowDuPont notes if the Corteva Distribution is abandoned or delayed beyond May 1, 2020; (vii) potential liability arising from fraudulent conveyance and similar laws in connection with the Corteva Distribution and/or the Dow Distribution; (viii) disruptions or business uncertainty, including from the Corteva Distribution, could adversely impact DowDuPont's business or financial performance and its ability to retain and hire key personnel; (ix) uncertainty as to the long-term value of DowDuPont common stock; (x) potential inability to access the capital markets; and (xi) risks to DowDuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's or Corteva, Inc.'s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DowDuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of DowDuPont's 2018 Annual Report on Form 10-K.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-completes-spin-off-of-dow-inc-300822253.html
SOURCE DowDuPont
WILMINGTON, Del., March 11, 2019 /PRNewswire/ -- DowDuPont (NYSE: DWDP) today announced two additional members of the future board of directors of Corteva Agriscience™, Agriculture Division of DowDuPont. They are Dr. Klaus Engel, former CEO of Evonik Industries, and Rebecca Liebert, who recently became senior vice president, automotive coatings at PPG after more than a decade in leadership roles at Honeywell International. With these additions, Corteva Agriscience has 11 members on its future Board.
Greg Page, non-executive chairman-elect of Corteva Agriscience and retired chairman and CEO of Cargill Inc., said, "Continuing to build a highly qualified board, with the right mix of diverse perspectives and experience, is a critical priority as we work with Corteva Agriscience's leadership to position it to drive sustainable growth as a global leader in agriculture. With the deep expertise in science-based innovation and effective leadership of complex global businesses that Klaus Engel and Rebecca Liebert bring, our Board is even stronger and better positioned to work with management to oversee the successful execution of Corteva Agriscience's strategy and deliver value for shareholders now and into the future."
"We're delighted Klaus Engel and Rebecca Liebert are joining the future Corteva board," said Jim Collins, Chief Executive Officer-elect of Corteva Agriscience. "Their strong backgrounds speak for themselves regarding their ability to advise management as we prepare to launch this pure-play agriculture company with its unique route to market and industry-leading new product pipeline."
DowDuPont remains on track to separate the Materials Science Division (Dow) on April 1, 2019, and the Agriculture (Corteva Agriscience) and Specialty Products (DuPont) Divisions on June 1, 2019.
In addition to Mr. Page, Dr. Engel and Ms. Liebert, Corteva Agriscience's future Board of Directors includes: Jim Collins, COO of the Agriculture Division of DowDuPont and CEO-elect of Corteva Agriscience; Edward D. Breen, CEO of DowDuPont; Lamberto Andreotti, former Chairman and CEO of Bristol-Myers Squibb; Robert A. Brown, President of Boston University; Michael O. Johanns, retired U.S. Senator and former U.S. Secretary of Agriculture; Lois D. Juliber, former Vice Chairman of Colgate-Palmolive Company; Lee M. Thomas, former Chairman and CEO of Rayonier Inc.; and Patrick J. Ward, CFO of Cummins Inc.
Biographies of New Directors
Klaus Engel, Ph.D., is the former CEO of Evonik Industries AG, a specialty chemical manufacturer, from 2009 to 2017, and previously was CEO of Degussa AG, a predecessor to Evonik, from 2006 to 2009. Prior to that, Dr. Engel was CEO of Brenntag AG/ Mülheim, a global chemical distribution company, since 2001. Earlier in his career, he held various senior positions in R&D, production, marketing and strategy planning at Chemische Werke Hüls/Marl, VEBA AG, Düsseldorf and Stinnes AG and Mülheim an der Ruhr. Dr. Engel has been a member of the supervisory board of National-Bank, Essen since 2011 and joined the advisory board of Ruhr-University, Bochum, Germany in 2018. He is honorary professor at University of Duisburg/Essen and Member of the Board of trustees of Bonner Akademie für angewandte Politik at University of Bonn.
Rebecca B. Liebert is senior vice president, automotive coatings at PPG, a publicly traded global manufacturer of paints, coatings and specialty materials. She joined PPG in 2018, following a decade at Honeywell in senior roles including most recently serving as President and CEO of Honeywell UOP, which develops technology for the petroleum refining, gas processing, petrochemical production, and major manufacturing industries. She started her career at Honeywell in the Electronic Materials business and moved to UOP in 2012. Earlier, she spent two years at Alcoa as President of Reynolds Food Packaging and started her career at Nova Chemicals.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience on Facebook, Instagram, LinkedIn, Twitter and YouTube.
Cautionary Statement About Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
DowDuPont plans to separate into three, independent, publicly traded companies-one for each of its agriculture, materials science and specialty products businesses (the "Intended Business Separations" and the transactions to accomplish the Intended Business Separations, the "separations").
In furtherance of the Intended Business Separations, DowDuPont is engaged in a series of reorganization and realignment steps to realign its businesses so that the assets and liabilities aligned with the materials science business will be held by legal entities that will ultimately be subsidiaries of Dow Holdings Inc. ("Dow") and the assets and liabilities aligned with the agriculture business will be held by legal entities that will ultimately be subsidiaries of Corteva Inc. ("Corteva"). Following this realignment, DowDuPont expects to distribute its materials science and agriculture businesses through two separate U.S. federal tax-free spin-offs in which DowDuPont stockholders, at the time of such spin-offs, will receive pro rata dividends of the shares of the capital stock of Dow and of Corteva, as applicable (the "distributions").
Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the Intended Business Separations, the separations and distributions. Forward-looking statements, including those related to the DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the separations and distributions, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which are beyond the DowDuPont's control. Some of the important factors that could cause DowDuPont's, Historical Dow's or Historical DuPont's actual results (including DowDuPont's agriculture business, materials science business or specialty products business as conducted by and through Historical Dow and Historical DuPont) to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits, including anticipated cost and growth synergies, from the integration of Historical Dow and Historical DuPont and the Intended Business Separations; (either directly or as conducted through Historical Dow and Historical DuPont), (ii) the incurrence of significant costs in connection with the integration of Historical Dow and Historical DuPont and the Intended Business Separations; (iii) risks outside the control of DowDuPont, Historical Dow and Historical DuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the Intended Business Separations, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, and other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and requirement to redeem $12.7 billion of DowDuPont notes if the Intended Business Separations are abandoned or delayed beyond May 1, 2020; (iv) potential liability arising from fraudulent conveyance and similar laws in connection with the separations and distributions; (v) disruptions or business uncertainty, including from the Intended Business Separations, could adversely impact DowDuPont's business (either directly or as conducted by and through Historical Dow or Historical DuPont), or financial performance and its ability to retain and hire key personnel; (vi) uncertainty as to the long-term value of DowDuPont common stock; (vii) potential inability to access the capital markets; and (viii) risks to DowDuPont's, Historical Dow's and Historical DuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for the DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce the DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U. S. Securities and Exchange Commission (the "Commission") as well as the preliminary registration statements on Form 10 of each of Dow and Corteva, in each case as may be amended from time to time in future filings with the Commission. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's, Historical Dow's, Historical DuPont's, Dow's or Corteva' s consolidated financial condition, results of operations, credit rating or liquidity. None of DowDuPont, Historical Dow, Historical DuPont, Dow or Corteva assumes any obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of the 2018 annual reports on Form 10-K of each of DowDuPont, Historical Dow and Historical DuPont and as set forth in the preliminary registration statements on Form 10 of each of Dow and Corteva, in each case as may be amended from time to time in future filings with the Commission.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-further-strengthens-future-board-of-directors-of-corteva-agriscience--agriculture-division-of-dowdupont-300809695.html
SOURCE DowDuPont
FORT LAUDERDALE, Fla., Feb. 28, 2019 /PRNewswire/ -- Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), Chief Executive Officer-elect, James C. Collins, Jr. today presented an update on Corteva Agriscience's ("Corteva" or "the Company") industry-leading pipeline during the 2019 Bank of America Merrill Lynch Global Agriculture & Chemicals Conference. Collins also shared a view on the Company's continued actions to accelerate its product launches and the strategic steps the Company is taking as it progresses toward the intended separation from DowDuPont on June 1, 2019.
In an update on the Company's strategy, Collins reaffirmed the priorities shared during its November Investor Day and highlighted the key strategic achievements across its Seed and Crop Protection businesses – detailing how, together with its digital capabilities and embedded competitive advantages, it expects to deliver sales of 1-2 percent above-market organic growth.
"We are building a different kind of agriculture company – a technology company with the future of agriculture and the needs of society at the forefront of what we do," Collins said. "We are building a pure-play agriculture company, with leading Seed and Crop Protection product portfolios, underpinned by digital capabilities and expertise that is differentiated in the way we innovate and go to market."
Delivering Value for Customers and Society
Collins presented a progress update on Corteva's R&D pipeline – and the disciplined innovation the Company continues to drive. The Company highlighted recent product launches that drove gains in 2018, as well as new and upcoming launches expected to enable continued progress toward the Company's stated strategic and financial targets.
"We advanced 13 technologies in our pipeline versus the prior year, with two moving to launch and five moving to ramp-up during this timeframe," Collins said. "This is tremendous progress and illustrates our innovation and product launch machine at work."
In the Seed platform, Collins shared additional detail on embedded capabilities, such as its germplasm advantage and advantaged routes to market globally. These advantages uniquely position Corteva to accelerate the near-term progress it is driving into the mid- and longer term by accelerating the speed of innovation and enabling a stronger product launch engine over time.
"Our germplasm advantage is an incredible asset, which, coupled with innovative discovery tools – is unique in the agriculture industry," Collins said. "We leverage this experience and expertise across the globe with local characterization to find the right solutions for each acre."
Collins shared how through the Company's technology and its continued innovation to drive yield advantage, Corteva is well-positioned to deliver the expected above-market organic growth it has targeted in Seed. As a proof point in this journey, Collins highlighted recent and upcoming trait launches – including a detailed view on its plans for its game-changing Enlist weed control system.
First-half 2019 activities for the Enlist system will focus on expanding grower experiences with Enlist E3™ soybeans through demonstration plots, field technology days and other opportunities. In the second-half of 2019, the Company shared that it will focus on commercial sales efforts. Robust ramp-up plans and extensive seed production helps ensure that Enlist E3™ soybeans are available to farmers in 2020. Finally, rounding out this system, the Company expects more than 20 percent of its 2,4 D sales in 2019 to be in Enlist formulations, including burndown applications in the Americas.
Commenting on the Enlist system, Collins said, "I have never seen such pent-up demand for a product that we believe is going to be a game changer in the industry."
In an update on the Crop Protection platform, Collins emphasized its focus - increasing differentiation to expand margins – striking a strong balance between patented and differentiated products and the cost-advantaged part of the portfolio.
"In Crop Protection, we expect to continue delivering above-market organic growth through not only disciplined capital allocation and a best-in-class cost structure – but also by launching innovative new products and delivering the returns we've committed to from these important technologies," Collins said.
Collins shared updates on how Crop Protection launches represented a key driver in Corteva's strategic progress in 2018. These launches drove organic growth of 17 percent and 10 percent in sales in the third quarter 2018 and fourth quarter 2018, respectively, with total sales growth of 10 percent and 6 percent, respectively.
Looking ahead to future portfolio innovation, Collins illustrated how Corteva's global scale, coupled with its localized research and customer relationship focus, are helping to maximize the productivity of its innovation and deliver needed solutions to growers around the world.
The Company provided an update on how its innovations in areas such as seed applied technology are leveraging the Company's strengths in both seed and crop protection to enable stronger relationships with its customers globally.
Collins also shared an update on the Company's digital agriculture offering – which rounds out Corteva's complete solution offering. Collins discussed Corteva's plans for global expansion of its Granular software solutions, beginning in 2019 with Brazil in addition to its existing footprint in Canada and Australia, and growing to additional countries in 2020.
"At Corteva, we have the expertise, capabilities and technology to work across Seed, Crop Protection and Digital – to find the right solution, a complete solution." "Here, we are providing farmers with more choice and empowering them with more information to make those choices to increase productivity and profitability of the farm."
DowDuPont invites investors to listen to the replay of the presentation through its website at www.dow-dupont.com/investors.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience on Facebook, Instagram, LinkedIn, Twitter and YouTube.
Cautionary Statement About Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the separation of Corteva from DowDuPont. Forward-looking statements, including those related to the DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the separation of Corteva, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which are beyond Corteva's control. Some of the important factors that could cause actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits, including anticipated cost and growth synergies, from the separations of the agriculture business from DowDuPont, (ii) risks outside the control of Corteva and DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the intended separations of the agriculture business from DowDuPont, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, and other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated from DowDuPont, and changes in the regulatory or legal environment and requirement to redeem $12.7 billion of DowDuPont notes if such separations are abandoned or delayed beyond May 1, 2020; (iv) potential liability arising from fraudulent conveyance and similar laws in connection with the separations and distributions; (v) disruptions or business uncertainty, including from such separation, could adversely impact Corteva or DowDuPont's business (either directly or indirectly), or financial performance and its ability to retain and hire key personnel; (vi) uncertainty as to the long-term value of Corteva's common stock; (vii) potential inability to access the capital markets; and (viii) risks to Corteva's or DowDuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for Corteva or DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce Corteva's or DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U. S. Securities and Exchange Commission (the "Commission") as well as the preliminary registration statement on Form 10 of Corteva, in each case as may be amended from time to time in future filings with the Commission. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's or Corteva's consolidated financial condition, results of operations, credit rating or liquidity. Neither DowDuPont nor Corteva assumes any obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of the 2018 annual report on Form 10-K of DowDuPont and as set forth in the preliminary registration statement on Form 10 of Corteva, as may be amended from time to time in future filings with the Commission.
Non-GAAP Financial Measures
This communication includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. These measures include DowDuPont Agriculture Division's organic sales and organic sales growth. DowDuPont and Corteva's management believes that these non-GAAP measures best reflect the ongoing performance of Corteva during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of Corteva and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. This data should be read in conjunction with Corteva's preliminary registration statement on Form 10 filing. DowDuPont and Corteva do not provide forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Companies are unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.
Organic sales and organic sales growth exclude the impact of foreign currency exchange rate fluctuation as well as acquisitions and divestitures.
Fourth quarter 2018 organic sales growth is defined as price and volume growth of 5% each and excludes foreign currency exchange rate fluctuation impacts as well as acquisitions and divestiture impacts of (4%) and 0%, respectively. Third quarter organic sales growth includes price and volume growth of 4% and 13%, respectively and excludes foreign currency exchange rate fluctuation impacts as well as acquisitions and divestiture impacts of (7%) and (0%), respectively. Revenues are for the Agriculture Division of DWDP for Q4 2017 and 2018 and are on a pro forma basis for the Q3 2017 comparable period, determined in accordance with Article 11 of Regulation S-X.
DowDuPont Unaudited Pro Forma Financial Information
This presentation contains pro forma segment net sales and segment operating EBITDA of the DowDuPont Agriculture Division. This unaudited pro forma financial information is based on the historical consolidated financial statements of both Dow and DuPont and was prepared to illustrate the effects of the Merger, assuming the Merger had been consummated on January 1, 2016. For all periods presented prior to the three months ended December 31, 2017, adjustments have been made, (1) for the preliminary purchase accounting impact, (2) for accounting policy alignment, (3) to eliminate the effect of events that are directly attributable to the Merger Agreement (e.g., one-time transaction costs), (4) to eliminate the impact of transactions between Dow and DuPont, and (5) to eliminate the effect of divestitures agreed to with certain regulatory agencies as a condition of approval for the Merger. The unaudited pro forma financial information was based on and should be read in conjunction with the separate historical financial statements and accompanying notes contained in each of the DowDuPont, Dow and DuPont Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K for the applicable periods and the historical financial statements and accompanying notes filed as exhibits to, and incorporated by reference into, Corteva's preliminary Form 10 registration statement. The pro forma financial statements were prepared in accordance with Article 11 of Regulation S-X, are for informational purposes only and are not necessarily indicative of what DowDuPont's results of operations actually would have been had the Merger been completed as of January 1, 2016, nor are they indicative of the future operating results of DowDuPont. For further information on the unaudited pro forma financial information, please refer to DowDuPont's Current Report on Form 8-K dated October 26, 2017 and the preliminary registration statement on Form 10 of Corteva filed on October 18, 2018.
TM, ®, SM Trademarks and service marks of Dow AgroSciences, DuPont or Pioneer, and their affiliated companies or their respective owners.
View original content to download multimedia:http://www.prnewswire.com/news-releases/corteva-agriscience-agriculture-division-of-dowdupont-provides-pipeline-update-300804201.html
SOURCE DowDuPont
WILMINGTON, Del. and WEST POINT, Iowa, Feb. 21, 2019 /PRNewswire/ -- Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), and MS Technologies™ are pleased to announce the U.S. launch of Enlist E3™ soybeans for 2019 planting, in one of the largest soybean technology system launches ever. The companies have completed their respective production plans, commercial offers, employee training and have received regulatory approvals in accordance with company product launch policies and Excellence Through Stewardship.
"Enlist E3™ soybeans are industry-leading triple-stack herbicide tolerant soybeans that give farmers broader choice and flexibility in selecting herbicide tolerance traits, genetics and crop protection solutions. We are pleased to offer this important technology to U.S. growers through many Corteva Agriscience™ seed brands as well as through many licensees," said Corteva Agriscience™ Chief Executive Officer-Elect, James C. Collins, Jr. "Enlist E3™ soybeans incorporate advanced herbicide tolerance and enable use of our Enlist One® and Enlist Duo® herbicides to give growers a complete solution for exceptional weed control."
"This is great news for U.S. soybean growers," notes Joseph Merschman, president of MS Technologies. "This announcement clears the way for even more soybean growers to experience the high-yielding elite genetics and exceptional weed control offered by the Enlist E3™ soybean system."
Jointly developed by Dow AgroSciences and MS Technologies, Enlist E3™ soybeans provide tolerance to new 2,4-D choline in Enlist Duo® and Enlist One® herbicides, as well as glyphosate and glufosinate herbicides. Enlist Duo® herbicide is a combination of new 2,4-D choline and glyphosate, a convenient blend for control of tough broadleaf and grass weeds. Enlist One® herbicide is a 2,4-D choline product offering the same excellent broadleaf weed control with greater tank-mix flexibility, including the ability to tank mix with qualified glufosinate products.
Farmers can apply Enlist™ herbicides in burn down through post-emergence in conjunction with Enlist E3™ soybeans to help control tough and glyphosate-resistant weeds; additional tolerance to glufosinate means they can utilize three post-emergence herbicide modes of action in Enlist E3™ soybean fields. An additional benefit of Enlist E3™ soybeans is no plant-back window after a burn down application of Enlist herbicides. With near-zero volatility and reduced potential for physical drift, Enlist™ herbicides with Colex-D® technology are designed to land and stay on target.
Enlist E3™ soybeans will be available for planting in 2019. Enlist E3™ soybeans will be available in commercial quantities across all Corteva Agriscience™ brands in 2020, including Corteva Agriscience's flagship Pioneer® brand, as well as from Stine Seed Company and Merschman Seed Company. Corteva Agriscience™ and MS Technologies also plan to broadly license Enlist E3™ soybean technology. The companies are currently in discussions with more than 100 seed brands. With this broad licensing approach, robust ramp-up plans and extensive seed production, Enlist E3™ soybeans are expected to be planted on more than 10 percent of U.S. and Canada soybean acres in 2020.
Enlist E3™ soybeans are approved for cultivation in the U.S., Canada and Brazil. Enlist E3™ soybeans have received import authorization in importing countries including China and the Philippines. Enlist E3™ soybeans should now be managed through standard grain handling practices in the U.S. for products containing biotechnology traits. For more information about Enlist E3™ soybeans and the Enlist™ weed control system, please review product labels, the Product Use Guide and the Technology Use Agreement and Enlist.com. For additional information about the status of regulatory authorizations for agricultural biotechnology seed products, please visit http://www.biotradestatus.com/.
To learn more about the Enlist™ weed control system, visit Enlist.com, follow us on Twitter at @EnlistOnline or go to our YouTube channel.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ seed brand, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience™ on Facebook, Instagram, LinkedIn, Twitter and YouTube.
About MS Technologies™
MS Technologies™ LLC is a leading trait, technology and soybean genetics provider. MS Technologies™ features a portfolio of in-house traits, as well as wide access to other traits and technologies through collaborative agreements with other parties. For more information on MS Technologies™, visit our website.
® TM SM Trademarks and service marks of Dow AgroSciences, DuPont or Pioneer, and their affiliated companies or their respective owners MS Technologies™ is a trademark of M.S. Technologies, L.L.C, 103 Avenue D, West Point, Iowa 52656 USA.
Enlist E3™ soybeans are jointly developed by Dow AgroSciences and MS Technologies.
The Enlist weed control system is owned and developed by Dow AgroSciences LLC. Enlist Duo® and Enlist One® herbicides are not registered for sale or use in all states or counties. Contact your state pesticide regulatory agency to determine if a product is registered for sale or use in your area. Enlist Duo and Enlist One are the only 2,4-D products authorized for use with Enlist crops. Consult Enlist herbicide labels for weed species controlled. Always read and follow label directions. ©2019 Dow AgroSciences LLC.
View original content to download multimedia:http://www.prnewswire.com/news-releases/corteva-agriscience-agriculture-division-of-dowdupont-and-ms-technologies-announce-launch-of-enlist-e3-soybeans-for-the-united-states-in-2019-300799940.html
SOURCE DowDuPont
WILMINGTON, Del., Feb. 21, 2019 /PRNewswire/ -- DuPont, the premier innovation provider of value-added specialized solutions that transform industries and everyday lives, will hold a meeting with sell-side analysts in New York City today.
During the meeting, Executive Chairman Elect Ed Breen, Chief Executive Officer Elect Marc Doyle and Chief Financial Officer Elect Jeanmarie Desmond will review DuPont's business strategy and previously disclosed financial information for the future company. The Specialty Products Division of DowDuPont is expected to transition to an independent company on June 1, 2019. The new DuPont is focused on providing technology-based materials and naturally sourced ingredient solutions in high growth markets. Leveraging its market-leading positions, deep customer relationships, R&D expertise, and best-in-class operating model, the company will be uniquely positioned to win in the marketplace, capitalize on high growth opportunities, and drive value for shareholders.
DuPont projects its dividends will be 30 to 40 percent of net income, or an estimate of approximately $900 million annually. Immediately following our transition to the new DuPont, we anticipate the new board will implement a share repurchase authorization consistent with a commitment to return excess capital to shareholders. Dividends and share repurchases are subject to DuPont Board of Director approval.
Members of the senior management team are scheduled to participate in additional meetings with the investment community, including shareholders, over the coming weeks.
The presentation materials for today's meeting can be accessed at http://www.dow-dupont.com/investors/events-and-presentations.
About DuPont, Specialty Products Division of DowDuPont
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, building and construction, health and wellness, food and worker safety. DowDuPont intends to separate the Specialty Products Division, which will be called DuPont, into an independent, publicly traded company. More information can be found at www.dow-dupont.com.
Cautionary Statement About Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
DowDuPont plans to separate into three, independent, publicly traded companies-one for each of its agriculture, materials science and specialty products businesses (the "Intended Business Separations" and the transactions to accomplish the Intended Business Separations, the "separations").
In furtherance of the Intended Business Separations, DowDuPont is engaged in a series of reorganization and realignment steps to realign its businesses so that the assets and liabilities aligned with the materials science business will be held by legal entities that will ultimately be subsidiaries of Dow Holdings Inc. ("Dow") and the assets and liabilities aligned with the agriculture business will be held by legal entities that will ultimately be subsidiaries of Corteva Inc.
("Corteva"). Following this realignment, DowDuPont expects to distribute its materials science and agriculture businesses through two separate U.S. federal tax-free spin-offs in which DowDuPont stockholders, at the time of such spin-offs, will receive pro rata dividends of the shares of the capital stock of Dow and of Corteva, as applicable (the "distributions"). DowDuPont after the separations and distributions referred to as DuPont.
Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the internal reorganization of DowDuPont's agriculture, materials science and specialty products businesses and the anticipated benefits thereof as well as the anticipated separation and distribution of Corteva Inc. ("Corteva") and Dow Holding Inc. ("Dow"). These and other forward-looking statements, including the failure to complete, or to make any filing or take any other action required to be taken to complete, the separations and distributions are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which are beyond our control. Some of the important factors that could cause the actual results of DuPont to differ materially from those projected in any such forward-looking statements include, but are not limited to (i) changes in credit ratings, (ii) risks associated with international sales and operations, (iii) availability, and variable costs, of raw materials and energy, (iv) competitive conditions and customer preferences, (v) the costs of complying with evolving regulatory requirements, (vi) disruptions to supply chains, information technology or network systems, (vii) protection of intellectual property, (viii) concerns regarding chemicals in commerce, including their environmental impact, (ix) failure to comply with government regulations, (x) impairments to goodwill or intangible assets, (xi) failure to effectively manage acquisitions, divestitures, alliances and other portfolio actions, (xii) litigation and other commitments and contingencies, (xiii) subjection to laws, regulations and mandates globally, (xiv) failure to increase productivity through sustainable operational improvements, (xv) the dependence of tax liabilities upon the distribution of income among the various jurisdictions in which we operate and (xvi) failure of risk management strategies.
Risks related to the separations and distributions and to achieving the anticipated benefits thereof include, but are not limited to, a number of conditions which could delay, prevent or otherwise adversely affect the separations and distributions including risks outside the control of DowDuPont, Historical Dow and Historical DuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the separations and distributions including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, and other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and requirement to redeem $12.7 billion of DowDuPont notes if the separations and distributions are abandoned or delayed beyond May 1, 2020; as well as other risks, including risks related to (i) our inability to achieve some or all of the benefits that we expect to receive from the separations and distributions, (ii) certain tax risks associated with the separations and distributions, (iii) our inability to make necessary changes to operate as a stand-alone company following the separations and distributions, (iv) the failure of our pro forma financial information to be a reliable indicator of our future results, (v) our inability to enjoy the same benefits of diversity, leverage and market reputation that we enjoyed as a combined company, (vi) restrictions under the intellectual property cross-license agreements, (vii) our inability to receive third-party consents required under the separation agreement, (viii) our customers, suppliers and others' perception of our financial stability on a stand-alone basis, (ix) non-compete restrictions under the separation agreement, (x) receipt of less favorable terms in the commercial agreements we will enter into with Dow and Corteva than we would have received from an unaffiliated third party and (xi) our indemnification of Dow and/or Corteva for certain liabilities. We assume no obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. For further discussion of certain important factors that could cause variations in our forward-looking statements, please consult the "Risk Factors" section of the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q of DowDuPont, The Dow Chemical Company ("Historical Dow") and E. I. du Pont de Nemours and Company ("Historical DuPont"), as well as the current reports and other information that DowDuPont, Historical DuPont, Historical How, Dow or DuPont may file with the Securities and Exchange Commission from time to time.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dupont-hosts-meeting-with-sell-side-analysts-300799096.html
SOURCE DuPont
WILMINGTON, Del., Feb. 21, 2019 /PRNewswire/ -- Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), will host a meeting with sell-side analysts this afternoon in New York City.
At the meeting, James C. Collins, Jr., chief executive officer-elect, and Greg Friedman, chief financial officer-elect, are expected to review strategy and priorities for shareholder value creation for Corteva Agriscience ("Corteva" or "the Company"), as it moves toward the intended separation from DowDuPont on June 1, 2019. Corteva will also provide financial guidance for the full year, as well as confirm its mid-term financial targets and intended uses for cash which were both presented at its investor day in November 2018.
"As a global pure-play agriculture company, Corteva is built to win through our customer-focused culture and unique ability to deliver a complete solution of innovative seed, crop protection and digital agriculture products to farmers, enabling them to maximize productivity and profitability as they work to meet rising demand in the face of fewer resources," said Jim Collins. "We believe we have an industry-leading pipeline, unique routes to market where we have leading positions and strong brands and a culture focused on driving cost competitiveness to deliver attractive returns on the investments we are making. We believe Corteva is well positioned to deliver above-market growth and to drive value for shareholders."
Performance Outlook
"We continue to drive sales performance by taking full advantage of our robust product pipeline. We are also focused on moving beyond merger-related synergies to delivering productivity, which is a cornerstone of our performance-based culture, and emphasizing continuous improvement across all of our processes," said Greg Friedman.
He continued, "We're looking forward to our sustained engagement with the investment community over the coming weeks as we expand on our strategy to capitalize on the significant opportunity we see ahead."
At today's meeting, Corteva will reiterate its outlook for the first half as the Agriculture Division of DowDuPont, provide its guidance for the full year 2019 and confirm its targets for performance over the mid-term, which collectively reflect a focus on delivering above-market growth.
For the full year 2019, the Agriculture Division of DowDuPont expects:
The Company's sales guidance for the full year 2019 assumes flat to 1 percent growth in seed sales for the industry globally and a 2 to 3 percent rise in crop protection sales for the industry, excluding the impact of currency. It also assumes stabilization of commodity prices, as crop inventories begin to come down, setting the stage for growth in the overall market beginning in 2020. The Company also assumes a shift in U.S. planted area from soybeans to spring wheat, corn and cotton. This overall shift in crops is expected to be margin neutral for Corteva.
Corteva, as a standalone company, also projects its dividends will be 25 to 35 percent of net income, or an estimate of approximately $400 million annually. Immediately following the spin, we anticipate the new board will implement a share repurchase authorization consistent with a commitment to return excess capital to shareholders. Dividends and share repurchases are subject to Corteva Board of Director approval.
Beyond 2019, in the mid-term, Corteva is targeting:
The presentation materials from the sell-side analyst meeting are available at http://www.dow-dupont.com/investors/events-and-presentations.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience™ provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ Seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience on Facebook, Instagram, LinkedIn, Twitter and YouTube.
Cautionary Statement About Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the separation of Corteva from DowDuPont. Forward-looking statements, including those related to the DowDuPont's ability to complete, or to make any filing or take any other action required to be taken to complete, the separation of Corteva, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which are beyond Corteva's control. Some of the important factors that could cause actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits, including anticipated cost and growth synergies, from the separations of the agriculture business from DowDuPont, (ii) risks outside the control of Corteva and DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the intended separations of the agriculture business from DowDuPont, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, and other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated from DowDuPont, and changes in the regulatory or legal environment and requirement to redeem $12.7 billion of DowDuPont notes if such separations are abandoned or delayed beyond May 1, 2020; (iv) potential liability arising from fraudulent conveyance and similar laws in connection with the separations and distributions; (v) disruptions or business uncertainty, including from such separation, could adversely impact Corteva or DowDuPont's business (either directly or indirectly), or financial performance and its ability to retain and hire key personnel; (vi) uncertainty as to the long-term value of Corteva's common stock; (vii) potential inability to access the capital markets; and (viii) risks to Corteva's or DowDuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for Corteva or DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce Corteva's or DowDuPont's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont's current, quarterly and annual reports and other filings made with the U. S. Securities and Exchange Commission (the "Commission") as well as the preliminary registration statement on Form 10 of Corteva, in each case as may be amended from time to time in future filings with the Commission. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's or Corteva's consolidated financial condition, results of operations, credit rating or liquidity. Neither DowDuPont nor Corteva assumes any obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of the 2018 annual report on Form 10-K of DowDuPont and as set forth in the preliminary registration statement on Form 10 of Corteva, as may be amended from time to time in future filings with the Commission.
Non-GAAP Financial Measures
This communication includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. These measures include DowDuPont Agriculture Division's Operating EBTIDA as adjusted to exclude currency, organic sales growth as well as an estimated full year operational tax rate for Corteva as a standalone company. DowDuPont and Corteva's management believes that these non-GAAP measures best reflect the ongoing performance of Corteva during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of Corteva and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. This data should be read in conjunction with Corteva's preliminary registration statement on Form 10, as amended from time to time. DowDuPont and Corteva do not provide forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because neither DowDuPont nor Corteva is able to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.
DowDuPont Ag Division's Operating EBITDA is defined as earnings (i.e., "Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses) excluding the impact of significant items. DowDuPont Ag Division's Operating EBITDA excluding currency is further adjusted to remove the impact of currency.
Organic sales and organic sales growth exclude the impact of foreign currency exchange rate fluctuation as well as acquisitions and divestitures.
The Full Year Operational tax rate for Corteva as a standalone company is defined as the effective income tax rate less the effect of exchange gains (losses), significant items, amortization expense associated with Historical DuPont's intangible assets and non-operating costs, net. Non-operating costs, net consists of non-operating pension and other post-employment benefit (OPEB) costs, environmental remediation and legal costs associated with legacy businesses and sites of Historical DuPont.
All products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks or registered trademarks of DowDuPont.
View original content to download multimedia:http://www.prnewswire.com/news-releases/corteva-agriscience-agriculture-division-of-dowdupont-hosts-meeting-with-sell-side-analysts-offers-2019-guidance-300799326.html
SOURCE DowDuPont
WILMINGTON, Del., Feb. 20, 2019 /PRNewswire/ -- James C. Collins, Jr., chief executive officer-elect of Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), will present at the Bank of America Merrill Lynch 2019 Global Agriculture and Materials Conference in Fort Lauderdale, FL, at 10:45 a.m. (ET) on Thursday, Feb. 28.
Collins will provide information on Corteva Agriscience's financial performance and highlight the company's industry-leading pipeline, as well as its ongoing progress toward its intended separation from DowDuPont on June 1, 2019. DowDuPont invites investors to join a live webcast of the presentation through its website. A replay of this presentation will also be available on the DowDuPont website following the webcast.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience on Facebook, Instagram, LinkedIn, Twitter and YouTube.
About DowDuPont
DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow Chemical Company and DuPont with the intent to form strong, independent, publicly traded companies in agriculture, materials science and specialty products sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges. For more information, please visit us at www.dow-dupont.com.
All products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks or registered trademarks of DowDuPont.
View original content to download multimedia:http://www.prnewswire.com/news-releases/corteva-agriscience-agriculture-division-of-dowdupont-to-participate-in-bank-of-america-merrill-lynch-2019-global-agriculture-and-materials-conference-300799118.html
SOURCE DowDuPont
WILMINGTON, Del., Feb. 20, 2019 /PRNewswire/ -- Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), today announced that it has acquired the Clearfield® Canola Production System ("Clearfield® canola") in Canada and the United States from BASF. Clearfield® canola is a globally-recognized non-genetically modified herbicide tolerance (HT) system, consisting of an herbicide tolerance trait and Imidazolinone (IMI) herbicides sold today in Canada primarily under the brand, Ares®.
"This bolt-on acquisition strengthens Corteva Agriscience's already established position in Clearfield® canola seeds and traits and positions us well to deliver a holistic trait and herbicide solution to growers – a strong proof point of our ongoing commitment to expanding grower choice and delivering a complete solution for farmers," said Rajan Gajaria, Executive Vice President Business Platforms for Corteva Agriscience. "This transaction supports Corteva Agriscience in supplying genetics for one of the most consumed vegetable oils globally, together with the heart-healthy Omega-9 oil segment, which reflects our continued focus on addressing consumer and farmer needs through differentiated offerings."
The acquisition enables Corteva Agriscience, which previously licensed the Clearfield® canola trait in both the Pioneer® and Brevant™ seeds (previously Nexera™) brands, to expand its position to include out-licensing of the Clearfield® canola trait to other seed companies in Canada and the United States. In addition, acquiring the imazamox/imazapyr herbicides under the brand name Ares® and the imazamox herbicides under the Tensile® brand in Canada, provides Corteva Agriscience with the full canola system to offer to its customers and potential licensee partners in these important markets.
The financial terms of the agreement were not disclosed.
About Corteva Agriscience™, Agriculture Division of DowDuPont Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience on Facebook, Instagram, LinkedIn, Twitter and YouTube.
® TM SM Trademarks and service marks of Dow AgroSciences, DuPont or Pioneer, and their affiliated companies or their respective owners.
Clearfield is a registered trademark of BASF and is used under license.
View original content to download multimedia:http://www.prnewswire.com/news-releases/corteva-agriscience-agriculture-division-of-dowdupont-acquires-clearfield-canola-production-system-in-canada-and-us-from-basf-300798369.html
SOURCE DowDuPont
WILMINGTON, Del., Feb. 14, 2019 /PRNewswire/ -- DuPont's board of directors declared regular quarterly dividends of $1.12-1/2 per share on the $4.50 series preferred stock and $0.87-1/2 cents per share on the $3.50 series preferred stock, both payable on April 25, 2019, to stockholders of record as shown on the books of the company at the close of business on April 10, 2019.
About DuPont
E. I. du Pont de Nemours and Company ("DuPont"), a subsidiary of DowDuPont (NYSE: DWDP), has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dupont-declares-regular-quarterly-dividend-on-preferred-stock-300796232.html
SOURCE DuPont
WILMINGTON, Del., Jan. 17, 2019 /PRNewswire/ -- Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), today announced plans for commercial launches of Enlist E3™ soybeans in Brazil, Canada and the United States, beginning in 2019. The Company also announced plans to expand the launch of Qrome® products across the U.S. Corn Belt.
"I am excited to announce one of the largest soybean technology system launches ever," said Corteva Agriscience Chief Executive Officer, James C. Collins, Jr. "Enlist E3™ soybeans incorporate advanced herbicide tolerance through three modes of action and enable use of our proprietary Enlist One™ and Enlist Duo® herbicides to provide more complete solutions to farmers."
"We are also announcing expanded availability of Qrome® products across a wider geography, and to more customers," said Collins. "Qrome® hybrids have earned the trust of American producers for consistent performance and have produced high yields by combining top-tier genetics, strong defensive traits and advanced seed treatments."
Enlist E3™ soybeans and Qrome® corn products are among more than 20 new technologies that Corteva Agriscience plans to launch by 20211. They are a key part of the Corteva Agriscience strategy to grow and to drive customer and shareholder value through the Company's combined seed and crop protection pipeline.
Enlist E3™ soybeans were jointly developed by Dow AgroSciences and MS Technologies. Both Enlist E3™ soybeans and grain produced from Qrome® corn products received import authorization from China in January 2019.
Enlist E3™ Soybeans
Enlist E3™ soybeans will be offered in Brazil, Canada and the U.S. across all Corteva Agriscience seed brands. Commercial sales will begin in 2019; timing will vary by country. First-half 2019 activities will focus on expanding grower experiences with Enlist E3™ soybeans through demonstration plots, field technology days and other opportunities. Second-half 2019 activities will focus on commercial sales efforts. Robust ramp-up plans and extensive seed production will ensure that Enlist E3™ soybeans are broadly available to farmers in 2020.
Corteva Agriscience is also engaged with numerous potential seed trait licensees and intends to broadly license Enlist E3™ soybean technology. This will enable farmers around the world to have broader choice and flexibility in selecting herbicide tolerance traits, genetics and crop protection solutions.
"Enlist E3™ soybeans are industry-leading triple-stack herbicide tolerant soybeans that allow Corteva Agriscience to better serve farmers with complementary seed and crop protection products," said Collins. "The fully-enabled launch of Enlist E3™ soybeans follows the successful introduction of top performing Enlist™ cotton varieties and Enlist™ corn hybrids in 2017 and 2018, respectively."
The Enlist E3™ soybean trait provides tolerance to new 2,4-D choline in Enlist Duo® and Enlist One™ herbicides, as well as glyphosate and glufosinate herbicides. Enlist Duo® herbicide is a combination of new 2,4-D choline and glyphosate, a convenient blend for control of tough broadleaf and grass weeds. Enlist One™ herbicide is a 2,4-D choline product offering the same excellent broadleaf weed control with greater tank-mix flexibility, including the ability to tank mix with qualified glufosinate products.
Growers can apply Enlist™ herbicides post-emergence to Enlist E3™ soybeans to help control glyphosate-resistant weeds; additional tolerance to glufosinate means they can utilize three post-emergence herbicide modes of action in Enlist E3™ soybean fields. With near-zero volatility and reduced potential for physical drift, Enlist™ herbicides with Colex-D® technology are designed to land and stay on target.
Qrome® Product Technology
Introductory quantities of Qrome® products will be available in the Pioneer® brand for 2019 planting across expanded geographies in the U.S. Corn Belt. For the 2020 growing season, Qrome® products are planned across a wide range of genetic platforms and maturities in Corteva Agriscience™ seed brands. Farmers who planted Pioneer® brand Qrome® products as part of limited launch in 2017 and 2018 across the Western U.S. Corn Belt reported strong performance and high yields.
"Qrome® products are the most optimized balance of insect protection and agronomic performance in the Corteva Agriscience product portfolio," said Collins.
Qrome® products feature a novel molecular stack of multiple insect protection traits and include two modes of action to control corn rootworm. Pioneer® brand Qrome® products have consistently delivered an average 5.5 bushel yield advantage over legacy triple-stack technology in multi-year research trials. In 2018 on-farm trials, Qrome® products held an average 10.2 bushel per acre advantage over all competitive products tested2.
Enlist E3™ soybeans are approved for cultivation in the U.S., Canada and Brazil. Qrome® products are approved for cultivation in the U.S. and Canada. Both Enlist E3™ soybeans and grain produced from Qrome® corn products have received import authorization in many importing countries, most recently in China. For additional information about the status of regulatory authorizations, please visit http://www.biotradestatus.com/.
To learn more about the Enlist™ weed control system, visit Enlist.com, follow us on Twitter at @EnlistOnline or go to our YouTube channel. Learn more about Qrome® products at Pioneer.com/Qrome.
1 Corteva Agriscience™, Agriculture Division of DowDuPont, Hosts Inaugural Investor Day
2 2018 Qrome performance data is based on the average of 244 comparisons made in the United States through Nov. 14, 2018. Comparisons are against all competitors and within a +/- 3 CRM of the competitive brand.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ seed brand, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience™ on Facebook, Instagram, LinkedIn, Twitter and YouTube.
®™Trademarks of DuPont, Dow AgroSciences and Pioneer and affiliated companies or their respective owners.
Enlist E3™ soybeans are jointly developed by Dow AgroSciences and MS Technologies.
The Enlist weed control system is owned and developed by Dow AgroSciences LLC. Enlist Duo and Enlist One herbicides are not registered for sale or use in all states or counties. Contact your state pesticide regulatory agency to determine if a product is registered for sale or use in your area. Enlist Duo and Enlist One herbicides are the only 2,4-D products authorized for use in Enlist crops. Always read and follow label directions. Dow AgroSciences LLC
View original content to download multimedia:http://www.prnewswire.com/news-releases/corteva-agriscience-agriculture-division-of-dowdupont-announces-enlist-e3-soybean-and-qrome-corn-commercial-launches-300780508.html
SOURCE DowDuPont
EDINA, Minn., Jan. 15, 2019 /PRNewswire/ -- Effective Jan. 15, 2019, or as contracts allow, DuPont Water Solutions, a part of the DuPont Safety & Construction business, today announced a global increase on the prices of ion exchange resins and reverse osmosis membranes used for water treatment and other industrial applications. Ion Exchange Resin price increases range from 5-20 percent, and Reverse Osmosis membrane price increases range from 5-10 percent for selected products/applications. This increase will take place with immediate effect and as contracts allow. The increase will vary according to the field of industry application and region.
DuPont Water Solutions is an industry leader committed to further investing in innovation, reliability, regulatory compliance and customer support.
For more information about DuPont Water Solutions, please visit www.dupont.com/water/.
About DuPont Safety & Construction
DuPont Safety & Construction, a DowDuPont Specialty Products Division business, is a global leader in products and solutions that protect what matters – people, structures and the environment – and enables its customers to win through unique capabilities, global scale and iconic brands including Corian®, Kevlar®, Nomex®, Tyvek®, Styrofoam™ and Filmtec®.
About DowDuPont Specialty Products Division
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, building and construction, health and wellness, food and worker safety. DowDuPont intends to separate the Specialty Products Division, which will be called DuPont, into an independent, publicly traded company. More information can be found at www.dow-dupont.com.
The DuPont Oval logo, DuPont™ and all products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates.
View original content:http://www.prnewswire.com/news-releases/dupont-water-solutions-announces-global-price-increase-for-ion-exchange-and-reverse-osmosis-products-300778139.html
SOURCE DuPont Water Solutions
WILMINGTON, Del., Nov. 28, 2018 /PRNewswire/ -- E. I. du Pont de Nemours and Company (the "Company") today announced early tender results as of the Early Tender Deadline, which was 5:00 p.m. New York City time on November 27, 2018, and pricing for the Company's previously announced cash tender offer (the "Tender Offer") to purchase its outstanding debt securities set forth in the table below (collectively, the "Notes" and each a "series" of Notes).
The complete terms of the Tender Offer are set forth in an offer to purchase and related letter of transmittal, each of which is dated November 13, 2018.
The principal amount of each series of Notes that was validly tendered and not validly withdrawn in the Tender Offer as of the Early Tender Deadline and the consideration to be paid for each series of Notes are set forth in the table below. The consideration to be paid in the Tender Offer for each series of Notes has been determined in the manner described in the offer to purchase by reference to a fixed spread over the yield to maturity of the applicable Reference U.S. Treasury Security specified in the table below and in the offer to purchase. Holders who, as of the Early Tender Deadline, had validly tendered and had not validly withdrawn their tendered Notes will receive the applicable "Total Consideration" listed in the table below, which includes an early tender payment of $30.00 per $1,000 principal amount of Notes accepted for purchase. In addition, holders whose Notes are accepted for purchase pursuant to the Tender Offer will also receive accrued and unpaid interest on their purchased Notes from the last interest payment date for such Notes to, but excluding, the settlement date.
Title of Security | CUSIP | Aggregate Principal | Aggregate | Percent of | Reference Security |
| Fixed | Total |
5.750% Senior Notes due 2019 | 263534 BW8 | $500,000,000 | $236,191,000 | 47.24% | 1.000% U.S. Treasury Notes | 2.433% | 50 bps | $1,008.12 |
4.625% Senior Notes due 2020 | 263534 BZ1 | $1,000,000,000 | $521,382,000 | 52.14% | 1.375% U.S. Treasury Notes | 2.784% | 20 bps | $1,018.03 |
3.625% Notes due 2021 | 263534 CB3 | $1,000,000,000 | $702,204,000 | 70.22% | 2.000% U.S. Treasury Notes | 2.853% | 15 bps | $1,012.70 |
4.250% Notes due 2021 | 263534 CE7 | $500,000,000 | $336,354,000 | 67.27% | 2.250% U.S. Treasury Notes | 2.859% | 15 bps | $1,027.79 |
2.800% Notes due 2023 | 263534 CK3 | $1,250,000,000 | $866,545,000 | 69.32% | 2.000% U.S. Treasury Notes | 2.910% | 12.5 bps | $1,000.00 (3) |
6.500% Debentures due 2028 | 263534 BG3 | $300,000,000 | $242,370,000 | 80.79% | 2.750% U.S. Treasury Notes | 3.065% | 12.5 bps | $1,260.29 |
5.600% Senior Notes due 2036 | 263534 BR9 | $400,000,000 | $357,308,000 | 89.33% | 4.750% U.S. Treasury Notes | 3.175% | 20 bps | $1,298.85 |
4.900% Notes due 2041 | 263534 CC1 | $500,000,000 | $445,133,000 | 89.03% | 4.750% U.S. Treasury Notes | 3.276% | 20 bps | $1,218.53 |
4.150% Notes due 2043 | 263534 CJ6 | $750,000,000 | $674,736,000 | 89.96% | 3.125% U.S. Treasury Notes | 3.322% | 15 bps | $1,110.37 |
(1) | Per $1,000 principal amount of Notes. |
(2) | Includes the early tender payment of $30.00 per $1,000 principal amount of Notes for each Series. |
(3) | Because the Total Consideration for the 2.800% Notes due 2023, as calculated pursuant to the fixed pricing formula in the offer to purchase, was less than $1,000 per $1,000 principal amount of the 2.800% Notes due 2023, the Total Consideration equals $1,000 per $1,000 principal amount of the 2.800% Notes due 2023. |
Subject to the terms and conditions of the Tender Offer, the Company expects that it will accept for purchase any and all Notes listed in the table above that were validly tendered and not validly withdrawn prior to the Early Tender Deadline.
The Tender Offer will expire at 11:59 p.m., New York City time, on December 11, 2018, unless extended. Holders of Notes must have validly tendered and not validly withdrawn their Notes on or before the Early Tender Deadline to be eligible to receive the applicable Total Consideration for their tendered Notes. After such time, the Notes may not be withdrawn except in certain limited circumstances where additional withdrawal rights are required by law. The Company expects that settlement for Notes that were validly tendered and not validly withdrawn on or before the Early Tender Deadline and are accepted for purchase will be on November 29, 2018.
The Tender Offer is not conditioned upon any minimum amount of Notes being tendered, and the Tender Offer may be amended, extended, terminated or withdrawn in whole or with respect to one or more series of Notes.
The Company's obligation to accept for purchase, and to pay for, any Notes validly tendered (and not validly withdrawn) and accepted for purchase pursuant to the Tender Offer is conditioned upon the satisfaction or waiver of the conditions described in the offer to purchase under the heading "Terms of the Tender Offer—Conditions to the Tender Offer." The "Financing Condition" (as defined in the offer to purchase under the heading "Terms of the Tender Offer—Conditions to the Tender Offer") has been satisfied as of November 28, 2018.
This press release is neither an offer to purchase nor a solicitation of an offer to sell securities. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such offer, solicitation, or sale would be unlawful. The Tender Offer is being made solely pursuant to terms and conditions set forth in the offer to purchase and related letter of transmittal.
Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC are serving as Dealer Managers for the Tender Offer. Questions regarding the Tender Offer may be directed to Credit Suisse Securities (USA) LLC at (800) 820-1653 (toll free) or (212) 538-1862 (collect), to Goldman Sachs & Co. LLC at (800) 828-3182 (toll free) or (212) 902-6941 (collect) or to J.P. Morgan Securities LLC at (866) 834-4666 (toll free) or (212) 834-4811 (collect). Requests for the offer to purchase or the letter of transmittal or the documents incorporated by reference therein may be directed to D.F. King & Co., Inc., which is acting as Tender and Information Agent for the Tender Offer, at the following telephone numbers: banks and brokers, (212) 269-5550; all others toll free at (866) 406-2285 or e-mail dowdupont@dfking.com.
About the Company
The Company is a subsidiary of DowDuPont Inc. (NYSE: DWDP) ("DowDuPont") a holding company comprised of The Dow Chemical Company and the Company with the intent to form three strong, independent, publicly traded companies in agriculture, materials science and specialty sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges.
Forward-Looking Statements
This communication contains forward-looking statements which may be identified by their use of words like "plans," "expects," "will," "anticipates," "believes," "intends," "projects," "estimates" or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the consummation of the Tender Offer, the strategies for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, and financial results of the Company and Corteva, Inc. ("Corteva"), and timing of, as well as expected benefits from, the separation of Corteva and The Dow Chemical Company from DowDuPont, are forward-looking statements.
For further discussion of some of the important factors that could cause the Company's actual results to differ materially from those projected in any such forward-looking statements, see the Risk Factors discussion set forth under Part I, Item 1A of the Company's annual report on Form 10-K and in the section titled "Risk Factors" (Part II, Item 1A) of its Form 10-Q for the fiscal quarter ended September 30, 2018. As the Company will be a subsidiary of Corteva following the separation of Corteva and The Dow Chemical Company from DowDuPont, factors that could cause actual results or events to differ materially from those anticipated also include matters included in the Registration Statement on Form 10 (File No. 001-38710) filed by Corteva, described under the sections entitled "Risk Factors" and "Business" in the Information Statement filed as Exhibit 99.1 to the Form 10. The Company disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law.
View original content to download multimedia:http://www.prnewswire.com/news-releases/e-i-du-pont-de-nemours-and-company-announces-early-tender-results-and-pricing-for-cash-tender-offer-300757129.html
SOURCE DuPont
WILMINGTON, Del., Nov. 15, 2018 /PRNewswire/ -- DuPont's board of directors today declared regular quarterly dividends of $1.12-1/2 per share on the $4.50 series preferred stock and $0.87-1/2 cents per share on the $3.50 series preferred stock, both payable on Jan. 25, 2019, to stockholders of record as shown on the books of the company at the close of business on Jan. 10, 2019.
About DuPont
DuPont, a subsidiary of DowDuPont (NYSE: DWDP), has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dupont-declares-regular-quarterly-dividend-on-preferred-stock-300751743.html
SOURCE DuPont
MIDLAND, Mich. and WILMINGTON, Del., Nov. 14, 2018 /PRNewswire/ -- DowDuPont Inc. (the "Company") (NYSE: DWDP) today announced the pricing of eight series of senior unsecured notes (the "Notes") in an aggregate principal amount of $12.7 billion, in a public underwritten offering, consisting of $1.5 billion of 3.766% Notes due 2020, $2.5 billion of 4.205% Notes due 2023, $1.85 billion of 4.493% Notes due 2025, $2.25 billion of 4.725% Notes due 2028, $1.65 billion of 5.319% Notes due 2038, $2.15 billion of 5.419% Notes due 2048, $500 million of Floating Rate Notes due 2020 and $300 million of Floating Rate Notes due 2023. After the previously announced separations and distributions of Dow Holdings Inc. ("Dow"), which is expected to occur on April 1, 2019, and of Corteva, Inc. ("Corteva"), which is expected to occur on June 1, 2019, DowDuPont expects to retain only its specialty products business and will then change its name to "DuPont." The offering is expected to close on Nov. 28, 2018, subject to customary closing conditions. Credit Suisse, Goldman Sachs & Co. LLC, J.P. Morgan, Barclays, BofA Merrill Lynch, Citigroup, Mizuho Securities, MUFG and SMBC Nikko are acting as joint book-running managers.
Each series of Notes will be a senior unsecured obligation of the Company and will rank equally with Company's future senior unsecured debt outstanding from time to time. The Notes will not be guaranteed by any of the Company's subsidiaries. Each series of Notes will continue to be a senior unsecured obligation of DuPont after the separations and distributions. If each of the separations and distributions has not been completed on or before May 1, 2020, or, if prior to such date, the Company has abandoned any of the separations or distributions, the Company will be required to redeem each series of Notes at a redemption price equal to 101 percent of the principal amount of such series of Notes, plus accrued and unpaid interest.
The Company intends to use the net proceeds of the offering, together with borrowings under term loan facilities (collectively, the "Financing"), to (i) reduce outstanding liabilities that would otherwise be allocable to its subsidiaries, Dow and Corteva, by approximately $2.024 billion and $10.1 billion, respectively, (ii) fund the repurchase up to $3.0 billion of the Company's common stock pursuant to the Company's previously announced share repurchase program and (iii) pay any related premiums, fees and expenses. In connection with the deleveraging of Corteva, the Company's subsidiary, E. I. du Pont de Nemours and Company ("Historical DuPont"), announced on Nov. 13, 2018 that it has commenced a cash tender offer for any and all of certain series of its outstanding notes.
The Company has filed a registration statement (including a prospectus) and a preliminary prospectus supplement with the Securities and Exchange Commission ("SEC") for the offering to which this communication relates. The preliminary prospectus supplement includes unaudited pro forma financial information of DuPont, derived from the Company's historical consolidated financial statements, adjusted to give effect to the merger of Historical DuPont and Historical Dow, the separations and distributions, and the Financing. Refer to "Unaudited Pro Forma Financial Information" and "Supplemental Pro Forma Information" within the preliminary prospectus supplement. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents that the Company has filed with the SEC for more complete information about the Company and this offering. You may get these documents for free by visiting EDGAR on the SEC Website at www.sec.gov. Alternatively, the Company, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling: Investor Relations at +1-302-774-4994; Credit Suisse Securities (USA) LLC toll-free at +1-800-221-1037; Goldman Sachs & Co. LLC toll-free at +1-866-471-2526; or J.P. Morgan Securities LLC at +1-212-834-4533.
This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sales of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
About DowDuPont™
DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow Chemical Company ("Historical Dow") and Historical DuPont. Historical Dow and Historical DuPont intend to pursue the separation of DowDuPont's leading businesses in one or more tax-efficient transactions, resulting in three independent, publicly traded companies: a global pure-play agriculture business; a pure-play materials science business; and a technology and innovation-driven specialty products business. The agriculture business will be consolidated under Corteva and the materials science business will be consolidated under Dow. After the separations and distributions, DowDuPont expects to retain only its specialty products business and will then change its name to "DuPont."
Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," "objective," and similar expressions and variations or negatives of these words.
Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the offering as well as the internal reorganization of DowDuPont's agriculture, materials science and specialty products businesses and the anticipated benefits thereof as well as the anticipated separation and distribution of Corteva and Dow. These and other forward-looking statements, including the failure to complete, or to make any filing or take any other action required to be taken to complete, the separations and distributions are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which are beyond our control. Some of the important factors that could cause the actual results of DuPont to differ materially from those projected in any such forward-looking statements include, but are not limited to (i) changes in credit ratings, (ii) risks associated with international sales and operations, (iii) availability, and variable costs, of raw materials and energy, (iv) competitive conditions and customer preferences, (v) the costs of complying with evolving regulatory requirements, (vi) disruptions to supply chains, information technology or network systems, (vii) protection of intellectual property, (viii) concerns regarding chemicals in commerce, including their environmental impact, (ix) failure to comply with government regulations, (x) impairments to goodwill or intangible assets, (xi) failure to effectively manage acquisitions, divestitures, alliances and other portfolio actions, (xii) litigation and other commitments and contingencies, (xiii) subjection to laws, regulations and mandates globally, (xiv) failure to increase productivity through sustainable operational improvements, (xv) the dependence of tax liabilities upon the distribution of income among the various jurisdictions in which we operate and (xvi) failure of risk management strategies.
Risks related to the separations and distributions and to achieving the anticipated benefits thereof include, but are not limited to, a number of conditions which could delay, prevent or otherwise adversely affect the separations and distributions, as well as other risks, including risks related to (i) our inability to achieve some or all of the benefits that we expect to receive from the separations and distributions, (ii) certain tax risks associated with the separations and distributions, (iii) our inability to make necessary changes to operate as a stand-alone company following the separations and distributions, (iv) the failure of our pro forma financial information to be a reliable indicator of our future results, (v) our inability to enjoy the same benefits of diversity, leverage and market reputation that we enjoyed as a combined company, (vi) restrictions under the intellectual property cross-license agreements, (vii) our inability to receive third-party consents required under the separation agreement, (viii) our customers, suppliers and others' perception of our financial stability on a stand-alone basis, (ix) non-compete restrictions under the separation agreement, (x) receipt of less favorable terms in the commercial agreements we will enter into with Dow and Corteva than we would have received from an unaffiliated third party and (xi) our indemnification of Dow and/or Corteva for certain liabilities. We assume no obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
For further discussion of certain important factors that could cause variations in our forward-looking statements, please consult the "Risk Factors" section of the preliminary prospectus supplement, the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q of DowDuPont, Dow and DuPont, as well as the current reports and other information that DowDuPont, Historical DuPont, Historical Dow, Dow or DuPont may file with the Securities and Exchange Commission from time to time.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-announces-pricing-of-senior-unsecured-notes-300750812.html
SOURCE DowDuPont
WILMINGTON, Del., Nov. 13, 2018 /PRNewswire/ -- Agriculture has the power to feed the growing population, creating stronger economies and communities around the world. At the heart of agriculture's success is the development of novel tools that farmers can use to produce higher yield potential in a more sustainable way. Corteva Agriscience™, Agriculture Division of DowDuPont, received a three prestigious Agrow Awards at the annual awards ceremony in London on November 12. Agrow is a leading provider of news, analysis and data to the global agriculture industry.
"The innovations recognized at this year's Agrow Awards showcase Corteva Agriscience at its best – collaborating to find novel, effective and integrated solutions that solve problems for our customers and their customers," said Neal Gutterson, Senior Vice President and Chief Technology Officer at Corteva Agriscience. "Importantly, many of these approaches also allow us to minimize our environmental footprint, which is a priority for us at Corteva Agriscience. We're honored to be recognized with these prestigious awards."
Corteva Agriscience took home wins in the following categories:
Best New Crop Protection Product or Trait:
Rinskor™ active is a new broad-spectrum herbicide with global utility in rice, controlling the most important grass, sedge, and broadleaf weeds that rob rice farmers of yield. Rinskor's differentiated mode of action controls resistant weeds at a fraction of the rate of other commonly-used herbicides. Based on toxicological, environmental, ecological and biological characteristics, the USEPA granted Rinskor a Reduced Risk Pesticide Designation with an expedited registration review. Rinskor was first launched in Chile in 2017 under the Loyant™ herbicide brand with subsequent launches occurring in the U.S., China, and South Korea in early 2018. The herbicide also was a 2018 winner of the United States' Green Chemistry Challenge Award.
Best Packaging Innovation:
The Lumigen™ Keg seed treatment package exemplifies how we actively identify opportunities for innovation beyond standard packaging systems for improved customer experience. The combined teams in Corteva Agriscience listened to customer needs and collaborated to develop an innovative solution that helps provide convenience, safety, and efficiency for the customer and the supply chain.
Best Industry Collaboration:
A new, open toxicogenomics platform holds the potential to revolutionize sustainable product innovation. Toxicogenomics is transforming the process of simply characterizing hazards to designing products with more favorable human health profiles. Individual companies develop these platforms behind their firewalls for competitive advantage, resulting in divergent approaches not embraced by the wider scientific and regulatory communities. A collaboration with the pharmaceutical company, Eli Lilly, and the Indiana Biosciences Research Institute yielded a new public toxicogenomics platform.
Corteva Agriscience also received a Highly Commended honor in the Best Stewardship Initiative category for a collaboration between their Brazil and Paraguay teams with farmers. The collaboration efforts ensure farmers in the region have training on how to use agricultural products correctly and effectively, and to date has reached 4,000 farmers with Good Agricultural Practices (GAP) training.
Corteva Agriscience was also recognized as finalists at the 2018 Agrow Awards in the following categories: Best R&D Pipeline, Best Outreach Program for their Plant Sciences Symposia Series in the Best Outreach Program category, Best Marketing Campaign for Instinct® and N-Serve® nitrogen stabilizers, and Best New Trait for their IPD072Aa which delivers a novel biotechnology trait to corn rootworm control.
The Agrow Awards were developed to recognize excellence in the crop protection and production industries. Entries are evaluated using a wide range of criteria by an independent judging panel consisting of a group of experts from around the world.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ Seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience on Facebook, Instagram, LinkedIn, Twitter and YouTube.
®, ™, SM Trademarks and service marks of DuPont, Pioneer or their respective owners.
View original content to download multimedia:http://www.prnewswire.com/news-releases/corteva-agriscience-agriculture-division-of-dow-dupont-wins-big-at-2018-agrow-awards-300749446.html
SOURCE DowDuPont
WILMINGTON, Del., Nov. 13, 2018 /PRNewswire/ -- E. I. du Pont de Nemours and Company (the "Company") today announced it has commenced a cash tender offer (the "Tender Offer") to purchase any and all of its outstanding debt securities set forth in the table below (collectively, the "Notes" and each a "series" of Notes). The complete terms of the Tender Offer are set forth in an offer to purchase and related letter of transmittal, each dated today. Consummation of the Tender Offer is subject to a number of conditions, including the Financing Condition (as defined below) and the absence of certain adverse legal and market developments. Subject to applicable law, the Company may waive certain of these conditions or extend, terminate or otherwise amend the Tender Offer.
Title of Security | CUSIP | Principal | Early Tender | Reference Security | Bloomberg Page | Fixed | Hypothetical Total |
5.750% Senior Notes due 2019 | 263534 BW8 | $500,000,000 | $30 | 1.000% U.S. Treasury Notes due March 15, 2019 | PX3 | 50 bps | $1,008.16 |
4.625% Senior Notes due 2020 | 263534 BZ1 | $1,000,000,000 | $30 | 1.375% U.S. Treasury Notes due January 15, 2020 | PX4 | 20 bps | $1,017.42 |
3.625% Notes due 2021 | 263534 CB3 | $1,000,000,000 | $30 | 2.000% U.S. Treasury Notes due January 15, 2021 | PX5 | 15 bps | $1,010.48 |
4.250% Notes due 2021 | 263534 CE7 | $500,000,000 | $30 | 2.250% U.S. Treasury Notes due March 31, 2021 | PX5 | 15 bps | $1,025.22 |
2.800% Notes due 2023 | 263534 CK3 | $1,250,000,000 | $30 | 2.000% U.S. Treasury Notes due February 15, 2023 | PX6 | 12.5 bps | $1,000.00(4) |
6.500% Debentures due 2028 | 263534 BG3 | $300,000,000 | $30 | 2.750% U.S. Treasury Notes due February 15, 2028 | PX7 | 12.5 bps | $1,249.13 |
5.600% Senior Notes due 2036 | 263534 BR9 | $400,000,000 | $30 | 4.750% U.S. Treasury Notes due February 15, 2037 | PX8 | 20 bps | $1,283.55 |
4.900% Notes due 2041 | 263534 CC1 | $500,000,000 | $30 | 4.750% U.S. Treasury Notes due February 15, 2041 | PX8 | 20 bps | $1,204.82 |
4.150% Notes due 2043 | 263534 CJ6 | $750,000,000 | $30 | 3.125% U.S. Treasury Notes due February 15, 2043 | PX8 | 15 bps | $1,098.42 |
________________________________________ | |
(1) | Per $1,000 principal amount of Notes. |
(2) | Includes the Early Tender Premium per $1,000 principal amount of Notes for each Series as set forth in this table. |
(3) | Hypothetical Total Consideration as of 11:00 a.m., New York City time, on November 9, 2018 and assuming Initial Settlement Date of November |
(4) | If the Total Consideration for the 2.800% Notes due 2023, as calculated pursuant to the fixed spread pricing formula described in the offer to |
The Company is offering to purchase any and all of the Notes listed in the table above. The current aggregate outstanding principal amount of such Notes is $6,200,000,000. The consideration paid for each series of Notes will be based on certain reference benchmarks determined at 11:00 a.m., New York City time, on Nov. 28, 2018, as described in the offer to purchase.
Holders of Notes that are validly tendered and not validly withdrawn on or before the Early Tender Deadline (as defined below) and accepted for purchase will receive the applicable "Total Consideration," which includes an early tender payment of $30 per $1,000 principal amount of Notes accepted for purchase (the "Early Tender Premium"). Holders of Notes who validly tender their Notes after the Early Tender Deadline and on or before the Expiration Time (as defined below) will only receive the applicable "Tender Consideration" per $1,000 principal amount of Notes tendered by such holders that are accepted for purchase, which is equal to the applicable Total Consideration minus the Early Tender Premium. Holders whose Notes are accepted for purchase pursuant to the Tender Offer will also receive accrued and unpaid interest on their purchased Notes from the last interest payment date for such Notes to, but excluding, the applicable settlement date.
The Tender Offer will expire at 11:59 p.m., New York City time, on Dec. 11, 2018, unless extended (such date and time, as the same may be extended, the "Expiration Time"). Holders of Notes must validly tender and not validly withdraw their Notes on or before 5:00 p.m., New York City time, on Nov. 27, 2018, unless extended (such date and time, as the same may be extended, the "Early Tender Deadline") to be eligible to receive the applicable Total Consideration for their tendered Notes, which includes the applicable Early Tender Premium set forth in the table above. After such time, the Notes may not be withdrawn, except in certain limited circumstances where additional withdrawal rights are required by law. Assuming the Tender Offer is not extended and the conditions to the Tender Offer are satisfied or waived, the Company expects that settlement for Notes validly tendered and not validly withdrawn on or before the Early Tender Deadline (the "Initial Settlement Date") will be on Nov. 29, 2018, and that settlement for Notes validly tendered after the Early Tender Deadline and on or before the Expiration Time will be on Dec. 12, 2018.
Subject to applicable law, the Tender Offer may be amended, extended, terminated or withdrawn with respect to one or more series of Notes at any time. If the Tender Offer is terminated with respect to any series of Notes without Notes of such series being accepted for purchase, Notes of such series tendered pursuant to the Tender Offer will promptly be returned to the tendering holders.
Prior to the Initial Settlement Date, DowDuPont Inc., the parent of the Company ("DowDuPont"), intends to complete a financing transaction (the "Financing Transaction"). After the previously announced separation and distribution of Dow Holdings Inc. ("Dow"), which is expected to occur on April 1, 2019, and of Corteva, Inc. ("Corteva"), which is expected to occur on June 1, 2019, DowDuPont expects to retain only its specialty products business and will then change its name to "DuPont." A portion of the net proceeds of the Financing Transaction will be contributed to the Company and used to finance the purchase of the Notes validly tendered and accepted for purchase pursuant to the Tender Offer, and to pay fees and expenses in connection with the Tender Offer.
The Company's obligation to accept for purchase, and to pay for, any Notes validly tendered (and not validly withdrawn) and accepted for purchase pursuant to the Tender Offer is conditioned upon the following having occurred or having been waived by the Company: (a) the consummation of the Financing Transaction resulting in proceeds sufficient to purchase all Notes validly tendered (and not validly withdrawn) and accepted for purchase by the Company and to pay fees and expenses in connection with the Tender Offer (the "Financing Condition"), and (b) satisfaction of the other conditions described in the offer to purchase.
This press release is neither an offer to purchase nor a solicitation of an offer to sell securities. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such offer, solicitation, or sale would be unlawful. The Tender Offer is being made solely pursuant to terms and conditions set forth in the offer to purchase and the related letter of transmittal.
Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC are serving as Dealer Managers for the Tender Offer. Questions regarding the Tender Offer may be directed to Credit Suisse Securities (USA) LLC at (800) 820-1653 (toll free) or (212) 538-1862 (collect), to Goldman Sachs & Co. LLC at (800) 828-3182 (toll free) or (212) 902-6941 (collect) or to J.P. Morgan Securities LLC at (866) 834-4666 (toll free) or (212) 834-4811 (collect). Requests for the offer to purchase or the letter of transmittal or the documents incorporated by reference therein may be directed to D.F. King & Co., Inc., which is acting as Tender and Information Agent for the Tender Offer, at the following telephone numbers: banks and brokers, (212) 269-5550; all others toll free at (866) 406-2285 or e-mail dowdupont@dfking.com.
About the Company
The Company is a subsidiary of DowDuPont Inc. (NYSE: DWDP), a holding company comprised of The Dow Chemical Company and the Company with the intent to form three strong, independent, publicly traded companies in agriculture, materials science and specialty sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges.
Forward-Looking Statements
This communication contains forward-looking statements which may be identified by their use of words like "plans," "expects," "will," "anticipates," "believes," "intends," "projects," "estimates" or other words of similar meaning. All statements that address expectations or projections about the future, including statements about consummation of the Financing Transaction, the strategies for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, and financial results of the Company and Corteva Inc. ("Corteva"), and timing of, as well as expected benefits from, the separation of Corteva and The Dow Chemical Company from DowDuPont, are forward-looking statements.
For further discussion of some of the important factors that could cause the Company's actual results to differ materially from those projected in any such forward-looking statements, see the Risk Factors discussion set forth under Part I, Item 1A of the Company's annual report on Form 10-K and in the section titled "Risk Factors" (Part II, Item 1A) of its Form 10-Q for the fiscal quarter ended September 30, 2018. As the Company will be a subsidiary of Corteva following the separation of Corteva and The Dow Chemical Company from DowDuPont, factors that could cause actual results or events to differ materially from those anticipated also include matters included in the Registration Statement on Form 10 (File No. 001-38710) filed by Corteva, described under the sections entitled "Risk Factors" and "Business" in the Information Statement filed as Exhibit 99.1 to the Form 10. The Company disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law.
Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the Company's control. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on the Company's business, results of operations and financial condition. Some of the important factors that could cause the Company's actual results to differ materially from those projected in any such forward-looking statements are: effect of competition and consolidation in the Company's industry; failure to successfully develop and commercialize the Company's pipeline; failure to obtain or maintain the necessary regulatory approvals for some of the Company's products; failure to enforce the Company's intellectual property rights or defend against intellectual property claims asserted by others; effect of competition from manufacturers of generic products; costs of complying with evolving regulatory requirements; effect of the degree of public understanding and acceptance or perceived public acceptance of the Company's biotechnology and other agricultural products; effect of changes in agricultural and related policies of governments and international organizations; impact of the Company's dependence on the Company's relationships or contracts with third parties; effect of disruptions to the Company's supply chain, information technology or network systems; effect of volatility in the Company's input costs; and failure to realize the anticipated benefits of the separation of Corteva and The Dow Chemical Company from DowDuPont, including failure to benefit from significant cost synergies through the DowDuPont Cost Synergy Program.
Additionally, there may be other risks and uncertainties that the Company is unable to currently identify or that the Company does not currently expect to have a material impact on its business. Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished.
View original content to download multimedia:http://www.prnewswire.com/news-releases/e-i-du-pont-de-nemours-and-company-announces-transaction-to-retire-up-to-6-2-billion-of-debt-securities-300749069.html
SOURCE DuPont
MIDLAND, Mich. and WILMINGTON, Del., Nov. 13, 2018 /PRNewswire/ -- DowDuPont Inc. (the "Company") (NYSE: DWDP) today announced the intention to offer, in a public underwritten transaction, senior unsecured notes (the "Notes"). After the previously announced separations and distributions of Dow Holdings Inc. ("Dow"), which is expected to occur on April 1, 2019, and of Corteva, Inc. ("Corteva"), which is expected to occur on June 1, 2019, DowDuPont expects to retain only its specialty products business and will then change its name to "DuPont." The principal amounts, interest rates and other key terms of the offering will be determined at the time of pricing. Credit Suisse, Goldman Sachs & Co. LLC and J.P. Morgan are acting as joint book-running managers.
Each series of Notes will be a senior unsecured obligation of the Company and will rank equally with Company's future senior unsecured debt outstanding from time to time. The Notes will not be guaranteed by any of the Company's subsidiaries. Each series of Notes will continue to be a senior unsecured obligation of DuPont after the separations and distributions. If each of the separations and distributions has not been completed on or before May 1, 2020, or, if prior to such date, the Company has abandoned any of the separations or distributions, the Company will be required to redeem each series of Notes at a redemption price equal to 101 percent of the principal amount of such series of Notes, plus accrued and unpaid interest.
The Company intends to use the net proceeds of the offering, together with borrowings under term loan facilities (collectively, the "Financing"), to (i) reduce outstanding liabilities that would otherwise be allocable to its subsidiaries, Dow and Corteva, by approximately $2.024 billion and $10.1 billion, respectively, (ii) fund the repurchase up to $3.0 billion of the Company's common stock pursuant to the Company's previously announced share repurchase program and (iii) pay any related premiums, fees and expenses. In connection with the deleveraging of Corteva, the Company's subsidiary, E. I. du Pont de Nemours and Company ("Historical DuPont"), today announced that it has commenced a cash tender offer for any and all of certain series of its outstanding notes.
The Company has filed a registration statement (including a prospectus) and a preliminary prospectus supplement with the Securities and Exchange Commission ("SEC") for the offering to which this communication relates. The preliminary prospectus supplement includes unaudited pro forma financial information of DuPont, derived from the Company's historical consolidated financial statements, adjusted to give effect to the merger of Historical DuPont and Historical Dow, the separations and distributions, and the Financing. Refer to "Unaudited Pro Forma Financial Information" and "Supplemental Pro Forma Information" within the preliminary prospectus supplement. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents that the Company has filed with the SEC for more complete information about the Company and this offering. You may get these documents for free by visiting EDGAR on the SEC Website at www.sec.gov. Alternatively, the Company, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling: Investor Relations at +1-302-774-4994; Credit Suisse Securities (USA) LLC toll-free at +1-800-221-1037; Goldman Sachs & Co. LLC toll-free at +1-866-471-2526; or J.P. Morgan Securities LLC at +1-212-834-4533.
This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sales of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
About DowDuPont™
DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow Chemical Company ("Historical Dow") and Historical DuPont. Historical Dow and Historical DuPont intend to pursue the separation of DowDuPont's leading businesses in one or more tax-efficient transactions, resulting in three independent, publicly traded companies: a global pure-play agriculture business; a pure-play materials science business; and a technology and innovation-driven specialty products business. The agriculture business will be consolidated under Corteva and the materials science business will be consolidated under Dow. After the separations and distributions, DowDuPont expects to retain only its specialty products business and will then change its name to "DuPont."
Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," "objective," and similar expressions and variations or negatives of these words.
Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the offering as well as the internal reorganization of DowDuPont's agriculture, materials science and specialty products businesses and the anticipated benefits thereof as well as the anticipated separation and distribution of Corteva and Dow. These and other forward-looking statements, including the failure to complete, or to make any filing or take any other action required to be taken to complete, the separations and distributions are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which are beyond our control. Some of the important factors that could cause the actual results of DuPont to differ materially from those projected in any such forward-looking statements include, but are not limited to (i) changes in credit ratings, (ii) risks associated with international sales and operations, (iii) availability, and variable costs, of raw materials and energy, (iv) competitive conditions and customer preferences, (v) the costs of complying with evolving regulatory requirements, (vi) disruptions to supply chains, information technology or network systems, (vii) protection of intellectual property, (viii) concerns regarding chemicals in commerce, including their environmental impact, (ix) failure to comply with government regulations, (x) impairments to goodwill or intangible assets, (xi) failure to effectively manage acquisitions, divestitures, alliances and other portfolio actions, (xii) litigation and other commitments and contingencies, (xiii) subjection to laws, regulations and mandates globally, (xiv) failure to increase productivity through sustainable operational improvements, (xv) the dependence of tax liabilities upon the distribution of income among the various jurisdictions in which we operate and (xvi) failure of risk management strategies.
Risks related to the separations and distributions and to achieving the anticipated benefits thereof include, but are not limited to, a number of conditions which could delay, prevent or otherwise adversely affect the separations and distributions, as well as other risks, including risks related to (i) our inability to achieve some or all of the benefits that we expect to receive from the separations and distributions, (ii) certain tax risks associated with the separations and distributions, (iii) our inability to make necessary changes to operate as a stand-alone company following the separations and distributions, (iv) the failure of our pro forma financial information to be a reliable indicator of our future results, (v) our inability to enjoy the same benefits of diversity, leverage and market reputation that we enjoyed as a combined company, (vi) restrictions under the intellectual property cross-license agreements, (vii) our inability to receive third-party consents required under the separation agreement, (viii) our customers, suppliers and others' perception of our financial stability on a stand-alone basis, (ix) non-compete restrictions under the separation agreement, (x) receipt of less favorable terms in the commercial agreements we will enter into with Dow and Corteva than we would have received from an unaffiliated third party and (xi) our indemnification of Dow and/or Corteva for certain liabilities. We assume no obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
For further discussion of certain important factors that could cause variations in our forward-looking statements, please consult the "Risk Factors" section of the preliminary prospectus supplement, the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q of DowDuPont, Dow and DuPont, as well as the current reports and other information that DowDuPont, Historical DuPont, Historical Dow, Dow or DuPont may file with the Securities and Exchange Commission from time to time.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-announces-public-offering-of-senior-unsecured-notes-300749067.html
SOURCE DowDuPont
JOHNSTON, Iowa, Nov. 9, 2018 /PRNewswire/ -- Corteva Agriscience™, Agriculture Division of DowDuPont, today announced a partnership with National 4-H Council and Pheasants Forever. The program, Corteva Grows Pollinator Habitat, will support monarch butterfly and pollinator habitat at Corteva Agriscience locations throughout the United States. Through this program, Corteva Agriscience will engage 4-H youth to help increase pollinator habitats and populations, supporting biodiversity. The program will also strengthen pollinator education efforts through Pheasants Forever's Youth Pollinator Habitat Program.
"We are committed to creating pollinator habitats, now and in the future, and our efforts are growing with the help of key partners who share our same vision," said Krysta Harden, Corteva Agriscience Senior Vice President of External Affairs and Chief Sustainability Officer. "There are many things we can do to support bees, butterflies and other pollinators, no matter where you live. Ensuring they have adequate habitats and plentiful food sources provides a strong foundation for pollinators."
At each location, Corteva Agriscience will provide land and financial support for the pollinator habitat, which will be planted and maintained, in part, by the site's employees and 4-H youth leaders. Pheasants Forever will provide expertise and support including habitat seed, site preparation, planting support and ongoing mowing. In addition to providing seasonal food supplies and a home to pollinators, the sites will be used to educate students on the benefits of pollinators and their habitats and grow youth with the awareness, passion and skills to be responsible stewards of our planet for generations to come. In the spring of 2019, the first sites will be planted. Additional site plantings will take place through 2020. The majority of locations reside along monarch butterfly flyway, the Interstate 35 corridor between Minnesota and Texas.
"This new partnership is helping to expand critical habitat areas for monarch butterflies, honey bees and grassland birds, while serving as an outdoor classroom for students and Corteva Agriscience employees nationwide," stated Howard Vincent, President and CEO of Pheasants Forever. "Our organization has taken a lead role nationally among conservation groups to promote this specific habitat variety, helping to boost agricultural production and provide diverse habitat for a wide host of species. We're very excited to contribute to this phenomenal partnership."
In addition, the Corteva Grows program will equip more than 30,000 4-H youth with tools and support they need to understand the importance of pollinators and how to build habitats in their communities to take action toward conserving them. Led by 4-H teen ambassadors, the pollinator curriculum will be delivered through peer-to-peer mentorship and direct teaching of younger audiences.
"Agriculture is a vital component to local communities across the U.S. and to our global economy," said Jennifer Sirangelo, President and CEO of National 4-H Council. "By partnering with Corteva Agriscience on this important initiative, youth will have the opportunity to learn-by-doing and grow the skills to pursue their passions and navigate challenges, especially those facing today's agriculture."
Pollinator health isn't new to Corteva Agriscience™. Earlier this year, to celebrate National Pollinator Week, employees at the Johnston, Iowa, Corteva Agriscience global business center constructed a pollinator demonstration garden. In 2017, employees led efforts to implement more than six acres of highly-diverse prairie habitat along a bike path that runs through the Johnston campus. In total, the campus has more than 10 acres of pollinator habitat. This new partnership is an extension of Corteva Agriscience's commitment to pollinator habitat expansion.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience™ provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ Seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience™, Agriculture Division of DowDuPont, on Facebook, Instagram, LinkedIn, Twitter and YouTube.
ABOUT 4-H
4-H, the nation's largest youth development organization, grows confident young people who are empowered for life today and prepared for career tomorrow. 4-H programs empower nearly 6 million young people across the U.S. through experiences that develop critical life skills. 4-H is the youth development program of our nation's Cooperative Extension System and USDA, and serves every county and parish in the U.S. through a network of 110 public universities and more than 3000 local Extension offices. The research-backed 4-H experience grows young people who are four times more likely to contribute to their communities; two times more likely to make healthier choices; two times more likely to be civically active; and two times more likely to participate in STEM programs.
About Pheasants Forever
Pheasants Forever, including its quail conservation division, Quail Forever, is the nation's largest nonprofit organization dedicated to upland habitat conservation. Pheasants Forever and Quail Forever have more than 149,000 members and 725 local chapters across the United States and Canada. Chapters are empowered to determine how 100 percent of their locally raised conservation funds are spent; the only national conservation organization that operates through this truly grassroots structure. Since creation in 1982, Pheasants Forever has spent $784 million on 530,000 habitat projects benefiting 17 million acres nationwide.
Learn more about 4-H at www.4-h.org, find us on Facebook at www.facebook.com/4-h and follow us on Twitter at www.twitter.com/4h.
All products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks or registered trademarks of DowDuPont.
View original content to download multimedia:http://www.prnewswire.com/news-releases/corteva-agriscience-agriculture-division-of-dowdupont-announces-corteva-grows-pollinator-habitat-with-4-h-and-pheasants-forever-300747519.html
SOURCE DowDuPont
WILMINGTON, Del., Oct. 18, 2018 /PRNewswire/ -- In response to market activity following the disclosure of a goodwill impairment related to DuPont's agriculture business, DowDuPont (NYSE: DWDP) today stated that the impairment is non-cash, reflects the effect of previously reported market conditions, and has no impact on its previously announced financial guidance for the Agriculture Division of DowDuPont for the full-year 2018.
The Company previously announced that it expects 2018 full-year results for its Agriculture Division to reflect flat net sales and a mid-single digits percent increase in operating EBITDA.
About DowDuPont™
DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow Chemical Company and DuPont with the intent to form strong, independent, publicly traded companies in agriculture, materials science and specialty products sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges.
For more information, please visit us at www.dow-dupont.com.
Divisional Disclaimer
Discussion of guidance on a divisional basis for Agriculture is based on the guidance for the Agriculture segment.
FORWARD-LOOKING STATEMENTS
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
On December 11, 2015, The Dow Chemical Company ("Dow") and E. I. du Pont de Nemours and Company ("DuPont") entered into an Agreement and Plan of Merger, as amended on March 31, 2017, (the "Merger Agreement") under which the companies would combine in an all-stock merger of equals transaction (the "Merger"). Effective August 31, 2017, the Merger was completed and each of Dow and DuPont became subsidiaries of DowDuPont.
Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including the intended separation, subject to approval of the Company's Board of Directors and customary closing conditions, of DowDuPont's agriculture, materials science and specialty products businesses in one or more tax-efficient transactions on anticipated terms (the "Intended Business Separations"). Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the Company's control. Some of the important factors that could cause DowDuPont's, Dow's or DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) costs to achieve and achieving the successful integration of the respective agriculture, materials science and specialty products businesses of Dow and DuPont, anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, productivity actions, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the combined operations; (ii) costs to achieve and achievement of the anticipated synergies by the combined agriculture, materials science and specialty products businesses; (iii) risks associated with the Intended Business Separations, including conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including possible issues or delays in obtaining required regulatory approvals or clearances related to the Intended Business Separations, associated costs, disruptions in the financial markets or other potential barriers; (iv) disruptions or business uncertainty, including from the Intended Business Separations, could adversely impact DowDuPont's business (either directly or as conducted by and through Dow or DuPont), or financial performance and its ability to retain and hire key personnel; (v) uncertainty as to the long-term value of DowDuPont common stock; and (vi) risks to DowDuPont's, Dow's and DuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for the Company, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce the Company's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in the current, quarterly and annual reports filed with the U. S. Securities and Exchange Commission by DowDuPont. While the list of factors presented here is, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's, Dow's or DuPont's consolidated financial condition, results of operations, credit rating or liquidity. None of DowDuPont, Dow or DuPont assumes any obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of DowDuPont's 2017 annual report on Form 10-K.
10/18/2018
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-statement-on-market-activity-300734072.html
SOURCE DowDuPont
MIDLAND, Mich. and WILMINGTON, Del., Oct. 18, 2018 /PRNewswire/ -- DowDuPont (NYSE: DWDP) today announced the filing of the initial Form 10 registration statement with the U.S. Securities and Exchange Commission for the separation of Corteva AgriscienceTM, Agriculture Division of DowDuPont. Corteva Agriscience remains on track to separate from DowDuPont on June 1, 2019.
The filing provides an overview of Corteva Agriscience's business, the strategy it is pursuing and management's priorities for the company. It also includes an assessment of its competitive advantages and market information as well as unaudited historical pro forma financial information for the intended company.
"This filing is another significant milestone in the process of preparing to separate Corteva Agriscience -- a leading, global pure-play, agriculture company offering farmers a comprehensive and balanced portfolio of seed, crop protection and digital solutions to boost their productivity and profitability," said James C. Collins Jr., Corteva Agriscience's Chief Executive Officer-elect.
"We are excited to launch a company that is uniquely positioned to drive industry-leading growth leveraging our powerful R&D engine and our new product pipeline while capitalizing on the benefits of our cost and growth synergies. Our strategy is to combine our proven innovation capabilities with our unmatched customer access to provide farmers with a portfolio of products and services that optimize yield and profitability, while improving environmental sustainability. We believe our competitive strengths, including our innovation pipeline and broad portfolio of products, leadership position in key markets and strong customer relationships, will enable us to create significant value for our customers and deliver strong returns to our shareholders."
"Corteva Agriscience is a global market leader with an experienced management team, operating in attractive markets," said Gregory R. Friedman, Corteva Agriscience's Executive Vice President and Chief Financial Officer-elect. "We are establishing the company with a lean cost structure to compete effectively in our target markets, while continuing to invest in our growth pipeline."
Included in Corteva Agriscience's 2017 pro forma income from continuing operations are approximately $175 - $225 million of leveraged functional and corporate costs that are not expected to continue post-spin but which do not meet the GAAP definition for discontinued operations treatment.
A brief presentation with an overview of the Form 10 filing is available on the investor relations pages of the company's website at http://www.dow-dupont.com/investors.
Consistent with the Form 10 process, this filing is expected to be iterative. Additional information regarding capital structure, dividend policy, governance, and other matters is expected to be filed in subsequent amendments to the document. DowDuPont intends to separate Corteva Agriscience on June 1, 2019. The Form 10 can be found on the investors section of the DowDuPont website at http://www.dow-dupont.com/investors.
As previously disclosed, DowDuPont is hosting an investor event on November 7-8 in New York, New York. The afternoon of November 8 will be devoted exclusively to Corteva Agriscience and will include presentations by Collins and Friedman. It also is expected to feature presenters including Executive Vice President Rajan Gajaria, Executive Vice President and Chief Commercial Officer Tim Glenn, and Senior Vice President and Chief Technology Officer Neal Gutterson, who will lead Corteva's business platforms, global commercial operations, and Research & Development, respectively. This event and the associated presentation materials will be available via webcast. For details, visit http://www.dow-dupont.com/investors.
DowDuPont (NYSE:DWDP) is a holding company comprised of The Dow Chemical Company and DuPont with the intent to form strong, independent, publicly traded companies in agriculture, materials science and specialty products sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges. For more information, please visit us at www.dow-dupont.com.
Cautionary Statement About Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
On December 11, 2015, The Dow Chemical Company ("Dow") and E. I. du Pont de Nemours and Company ("DuPont") entered into an Agreement and Plan of Merger, as amended on March 31, 2017, (the "Merger Agreement") under which the companies would combine in an all-stock merger of equals transaction (the "Merger"). Effective August 31, 2017, the Merger was completed and each of Dow and DuPont became subsidiaries of DowDuPont.
Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including the intended separation, subject to approval of the Company's Board of Directors of DowDuPont's agriculture, materials science and specialty products businesses in one or more tax-efficient transactions on anticipated terms (the "Intended Business Separations"). Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the Company's control. Some of the important factors that could cause DowDuPont's, Dow's or DuPont's actual results (including DowDuPont's agriculture business, either directly or as conducted by and through Dow and DuPont) to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) costs to achieve and achieving the successful integration of the respective agriculture, materials science and specialty products businesses of DowDuPont (either directly or as conducted by and through Dow and DuPont), anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, productivity actions, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the combined operations; (ii) costs to achieve and achievement of the anticipated synergies by the combined agriculture, materials science and specialty products businesses; (iii) risks associated with the Intended Business Separations, including conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including associated costs, disruptions in the financial markets or other potential barriers; (iv) disruptions or business uncertainty, including from the Intended Business Separations, could adversely impact DowDuPont's business (either directly or as conducted by and through Dow or DuPont), or financial performance and its ability to retain and hire key personnel; (v) uncertainty as to the long-term value of DowDuPont common stock; and (vi) risks to DowDuPont's, Dow's and DuPont's business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for the Company, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce the Company's intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities; as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in the current, quarterly and annual reports filed with the U. S. Securities and Exchange Commission by DowDuPont, as well as the preliminary registration statement on Form 10 of Corteva. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's, Dow's, DuPont's or Corteva's consolidated financial condition, results of operations, credit rating or liquidity. None of DowDuPont, Dow or DuPont assumes any obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" (Part I, Item 1A) of the 2017 annual report on Form 10-K of each of DowDuPont and DuPont and the preliminary registration statement on Form 10 of Corteva, Inc., in each case, as amended from time to time.
The Dow Diamond, DuPont Oval logo, DuPont™, the DowDuPont logo and all products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks, service marks or registered trademarks of The Dow Chemical Company, E. I. du Pont de Nemours and Company, DowDuPont Inc. or their affiliates.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dowdupont-announces-filing-of-initial-form-10-registration-statement-for-corteva-agriscience-300733918.html
SOURCE DowDuPont
INDIANAPOLIS, Oct. 15, 2018 /PRNewswire/ -- Today, Corteva Agriscience™, Agriculture Division of DowDuPont, received a 2018 Green Chemistry Challenge Award for Rinskor™ active, a rice herbicide that provides a sustainable solution for rice farmers to control grass, broadleaf and sedge weeds. The American Chemical Society's Green Chemistry Institute's award, given to companies or institutions that have developed a new process or product that helps protect public health and the environment, is the United States' most prestigious award program for green chemistry innovations.
Green chemistry focuses on designing chemicals that reduce or eliminate the use of hazardous substances and that reduce pollution at its source. Corteva Agriscience and its heritage companies are no stranger to winning Green Chemistry Challenge Awards. This will be the sixth win for the heritage businesses that make up the Agriculture Division of DowDuPont.
"Rinskor active is a prime example of what advancing innovation means for agriculture," said Krysta Harden, Corteva Agriscience Vice President of External Affairs and Chief Sustainability Officer. "Sustainable technology can solve problems for farmers while protecting the planet, and we're honored to have yet another Green Chemistry Challenge winner as part of our crop protection portfolio."
Launched in the U.S. market in 2018, Rinskor active has favorable human health and environmental profiles, with low persistence in soil and water and low toxicity to other organisms such as birds, insects and fish. Rinskor active has low use rates, which are up to 153 times lower than other commonly-used rice herbicides, pose minimal risk to farmers, applicators and to other non-target animals and plants when used according to the label recommendations.
Because of its agronomic and environmental benefits, Rinskor active is a pivotal tool for helping rice farmers manage resistant or tough-to-control weeds. It will contribute to food security by sustaining rice production in an environmentally responsible way for years to come.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience™ provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ Seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience™, Agriculture Division of DowDuPont, on Facebook, Instagram, LinkedIn, Twitter and YouTube.
All products, unless otherwise noted, denoted with ™, SM or ® are trademarks or registered trademarks of DowDuPont.
View original content to download multimedia:http://www.prnewswire.com/news-releases/rinskor-active-earns-green-chemistry-challenge-award-300731092.html
SOURCE DowDuPont
In a survey conducted by Corteva Agriscience™, Agriculture Division of DowDuPont, women say they see progress but that it's too slow. In addition to citing financial disparities, fewer than half feel acknowledged, heard, or empowered to make decisions.
WILMINGTON, Del., Oct. 15, 2018 /PRNewswire/ -- Women in agriculture around the world, whether in developing or developed countries, say widespread gender discrimination persists and poses obstacles to their ability to help feed the world, according to a new study from Corteva Agriscience™, Agriculture Division of DowDuPont.
The study was released to coincide with today's celebration of the International Day of Rural Women. Corteva Agriscience commissioned the 17-country study to underscore the importance of women in agriculture and to identify barriers to their full and successful participation. The study included 4,160 respondents living in both the developed and developing world on five different continents.
"We conducted this study to further understand the current status of women farmers around the world - from the largest farms in the most advanced economies to the smallest subsistence farms in the developing world - and to create a baseline from which we can measure progress going forward," said Krysta Harden, Vice President External Affairs and Chief Sustainability Officer of Corteva Agriscience.
IDENTIFYING BARRIERS TO SUCCESS
The survey's findings reveal that although women are overwhelmingly proud to be in agriculture, they perceive gender discrimination as widespread, ranging from 78 percent in India to 52 percent in the United States. Only half say they are equally successful as their male counterparts; 42 percent say they have the same opportunities as their male counterparts, and only 38 percent say they are empowered to make decisions about how income is used in farming and agriculture.
Almost 40 percent of the respondents reported lower income than men and less access to financing. High on the list of concerns were financial stability, the welfare of their families and achieving a work/life balance.
Many said they need more training to take advantage of the agricultural technology that has become essential for financial success and environmental stewardship. This desire for training emerged as the most commonly cited need among the respondents for removing gender inequality obstacles. The numbers significantly exceeded 50 percent for all 17 countries, with Brazil, Nigeria, Kenya, Mexico and South Africa leading the way.
REMOVING THE OBSTACLES
The majority of women reported progress toward gender equality, but 72 percent said it would take one to three decades or more to achieve full equality. Five key actions, according to the respondents, were identified to remove obstacles to equality:
"While we know women make up almost half of the world's farmers, this study validates challenges continue to persist, holding back not only the women in agriculture but also the people who depend on them: their families, their communities, and the societies. Identifying the existence of these challenges is the first step in removing obstacles for rural women farmers to achieve their full potential," said Harden.
ON THE SURVEY
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience™ provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ Seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience™, Agriculture Division of DowDuPont, on Facebook, Instagram, LinkedIn, Twitter and YouTube.
All products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks or registered trademarks of DowDuPont.
View original content:http://www.prnewswire.com/news-releases/women-in-agriculture-say-barriers-to-equality-persist-removal-could-take-decades-17-country-study-reveals-300729910.html
SOURCE DowDuPont
WILMINGTON, Del., Oct. 8, 2018 /PRNewswire/ -- DuPont today announced Darrell Ford has been named chief human resources officer for the Specialty Products Division of DowDuPont, which is expected to become an independent company (future DuPont) by June 1, 2019. Ford's appointment is effective Nov. 5, 2018. He will report to Marc Doyle, CEO-elect for future DuPont and chief operating officer, DowDuPont Specialty Products Division.
Ford joins DuPont from Xerox, where he served as chief human resources officer responsible for the company's human resource planning, sourcing, talent management, leadership development, pay and rewards, diversity, work environment and industrial relations. Ford's previous experience includes HR leadership roles at Advanced Micro Devices, Shell Oil and Honeywell International.
"Innovation is at the heart of our company and our employees are the driving force behind solving our customers' most complex challenges," said Doyle. "Darrell's experience in leading global workforce strategies for diverse technology-based companies make him well-suited to lead the human resources function for the new DuPont. I look forward to him joining our executive leadership team."
Ford, 53, holds a bachelor's degree in Psychology, and an MBA and law degree from Rutgers University.
About DowDuPont Specialty Products Division
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, building and construction, health and wellness, food and worker safety. DowDuPont intends to separate the Specialty Products Division, which will be called DuPont, into an independent, publicly traded company. More information can be found at www.dow-dupont.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/darrell-ford-named-chief-human-resources-officer-for-specialty-products-dupont-division-of-dowdupont-300726862.html
SOURCE DuPont
WILMINGTON, Del., Oct. 3, 2018 /PRNewswire/ -- For over 200 years, DuPont has been synonymous with life-changing discoveries and scientific know-how, reinventing ourselves along the way. As we take the next step toward becoming the new DuPont, we are unveiling a fresh global brand identity and logo that recognizes our heritage while conveying our focus on a customer-led innovation strategy and purpose-driven culture.
DowDuPont announced in February 2018 that its Specialty Products Division would carry the DuPont name when it becomes an independent company, which is expected about June 1, 2019 subject to approval of the DowDuPont Board of Directors and other customary closing conditions.
"Our new branding is one of many steps we are taking in DuPont's transformation and amplifies what we do; help our customers solve complex problems, and turn their best ideas into real-world products and solutions," said Barbara Pandos, chief communications officer, Specialty Products Division of DowDuPont. "It preserves the legacy shape of the iconic DuPont Oval, which for more than a century has provided a seal of quality, performance and trust, but it will no longer be constrained by an elliptical border – signaling a collaborative and open flow of ideas and innovation."
As a premier innovation company, DuPont discovers and delivers value-added specialized solutions that foster sustainable progress and enrich people's everyday lives. DuPont's new brand purpose – "To empower the world with the essential innovations to thrive" – builds upon a rich history of discovery and progress. Some examples of DuPont's best-known product brands include Kevlar® fiber, Tyvek® high-performance materials, Sorona® renewably sourced fiber and Danisco® food ingredients; and the new DuPont portfolio includes Great Stuff™ insulating foam sealant.
Beginning today, the new logo will appear and be featured on our digital channels. Packaging and signage will be changed over gradually following the launch of the new company.
For more information and images on our brand journey and history, please visit us at new.dupont.com and follow us on Twitter @DuPont_news with the #makersofnew.
About DowDuPont Specialty Products Division
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, building and construction, health and wellness, food and worker safety. DowDuPont intends to separate the Specialty Products Division, which will be called DuPont, into an independent, publicly traded company. More information can be found at www.dow-dupont.com.
The DuPont Oval logo, DuPont™ and all products, unless otherwise noted, denoted with ™, ℠or ® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dupont-sets-the-stage-for-a-future-that-is-wide-open-300723626.html
SOURCE DuPont
WILMINGTON, Del., and ST. LOUIS, May 16, 2018 /PRNewswire/ -- Corteva Agriscience™ Agriculture Division of DowDuPont (NYSE: DWDP) and Monsanto Company (NYSE: MON) announced today the completion of a licensing agreement for next-generation technology for insect control in corn for the U.S. and Canada that will expand options for farmers fighting corn rootworm, dubbed the "billion dollar bug" for the damage it causes. Corteva Agriscience™ will receive a license to stack Monsanto's Corn Rootworm III and MON89034 traits with Corteva Agrisciences's insect control traits. This agreement enables the development of the next generation of insect control technology for above and below ground insect pests, and will be offered with the Enlist® herbicide tolerant trait for corn. Financial details of the agreement are not being disclosed.
"This collaboration demonstrates the commitment Corteva Agriscience™ has to bringing greater choice to growers, helping them increase their productivity and profitability," said Tony Klemm, Global Corn Portfolio Leader, Corteva Agriscience™, Agriculture Division of DowDuPont. "The combination of Corn Rootworm III with Corteva Agriscience™ molecular stack for insect control and the Enlist® corn trait will give our customers the ability to protect yield while extending the durability of industry-leading insect trait technology."
"Monsanto's broad licensing approach continues to put valuable, cost-effective tools into the hands of farmers when they need them most," said Calvin Treat, Monsanto's Global Soy and Corn Technology Lead. "We view this agreement as an endorsement for the novel mode of action that Monsanto's Corn Rootworm III trait brings to farmers, as it builds on the current products planted today by adding a new RNAi mode of action that enhances effectiveness against one of the industry's most destructive insect pests. Corn Rootworm III offers increased control and additional durability against the corn rootworm by providing three distinct methods of protection. Through the use of RNAi we're able to target and control rootworms with a novel mode of action that's different than the Bt class of proteins that is used in other insect-control products."
This new next generation product combines Corteva Agriscience™ molecular stack for insect control and Enlist® with Monsanto's Corn Rootworm III and MON89034 (Bt) to create a broad-spectrum insect control product with multiple modes of action for above- and below-ground pests. Pending applicable regulatory reviews, it will be offered with the Enlist® tolerant trait for corn, which provides tolerance to new 2,4-D choline, and FOP herbicides in addition to the base glyphosate tolerance. This brings additional benefits to farmers, offering more weed control options and greater flexibility.
About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE: DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience™ provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ Seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.
Follow Corteva Agriscience™, Agriculture Division of DowDuPont, on Facebook, Instagram, LinkedIn, Twitter and YouTube.
About DowDuPont
DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow Chemical Company and DuPont with the intent to form strong, independent, publicly traded companies in agriculture, materials science and specialty products sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges. For more information, please visit us at www.dow-dupont.com.
Follow Corteva Agriscience™, Agriculture Division of DowDuPont, on Facebook, Instagram, LinkedIn, Twitter and YouTube.
About Monsanto
Monsanto is committed to bringing a broad range of solutions to help nourish our growing world. We produce seeds for fruits, vegetables and key crops – such as corn, soybeans, and cotton – that help farmers have better harvests while using water and other important resources more efficiently. We work to find sustainable solutions for soil health, help farmers use data to improve farming practices and conserve natural resources, and provide crop protection products to minimize damage from pests and disease. Through programs and partnerships, we collaborate with farmers, researchers, nonprofit organizations, universities and others to help tackle some of the world's biggest challenges. To learn more about Monsanto, our commitments and our more than 20,000 dedicated employees, please visit monsanto.com. Follow our business on Twitter® at twitter.com/MonsantoCo.
All products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks or registered trademarks of their respective companies.
Cautionary Statement About Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," similar expressions, and variations or negatives of these words.
On December 11, 2015, The Dow Chemical Company ("Dow") and E. I. du Pont de Nemours and Company ("DuPont") announced entry into an Agreement and Plan of Merger, as amended on March 31, 2017, (the "Merger Agreement") under which the companies would combine in an all-stock merger of equals transaction (the "Merger Transaction"). Effective August 31, 2017, the Merger Transaction was completed and each of Dow and DuPont became subsidiaries of DowDuPont Inc. ("DowDuPont"). For more information, please see each of DowDuPont's, Dow's and DuPont's latest annual, quarterly and current reports on Forms 10-K, 10-Q and 8-K, as the case may be, and the joint proxy statement/prospectus included in the registration statement on Form S-4 filed by DowDuPont with the SEC on March 1, 2016 (File No. 333-209869), as last amended on June 7, 2016, and declared effective by the SEC on June 9, 2016 (the "Registration Statement") in connection with the Merger Transaction.
Forward-looking statements by their nature address matters that are, to different degrees, uncertain, including the intended separation of DowDuPont's agriculture, materials science and specialty products businesses in one or more tax efficient transactions on anticipated terms (the "Intended Business Separations"). Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company's control. Some of the important factors that could cause DowDuPont's, Dow's or DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) successful integration of the respective agriculture, materials science and specialty products businesses of Dow and DuPont, including anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, productivity actions, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the combined operations; (ii) impact of the divestitures required as a condition to consummation of the Merger Transaction as well as other conditional commitments; (iii) achievement of the anticipated synergies by DowDuPont's agriculture, materials science and specialty products businesses; (iv) risks associated with the Intended Business Separations, including those that may result from the comprehensive portfolio review undertaken by the DowDuPont board, changes and timing, including a number of conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including possible issues or delays in obtaining required regulatory approvals or clearances related to the Intended Business Separations, disruptions in the financial markets or other potential barriers; (v) the risk that disruptions from the Intended Business Separations will harm DowDuPont's business (either directly or as conducted by and through Dow or DuPont), including current plans and operations; (vi) the ability to retain and hire key personnel; (vii) potential adverse reactions or changes to business relationships resulting from the completion of the merger or the Intended Business Separations; (viii) uncertainty as to the long-term value of DowDuPont common stock; (ix) continued availability of capital and financing and rating agency actions; (x) legislative, regulatory and economic developments; (xi) potential business uncertainty, including changes to existing business relationships, during the pendency of the Intended Business Separations that could affect the company's financial performance and (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks, as well as other risks associated with the merger and the Intended Business Separations, are more fully discussed in (1) the Registration Statement and (2) the current, quarterly and annual reports filed with the SEC by DowDuPont and to the extent incorporated by reference into the Registration Statement, by Dow and DuPont. While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's, Dow's or DuPont's consolidated financial condition, results of operations, credit rating or liquidity. None of DowDuPont, Dow or DuPont assumes any obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
View original content:http://www.prnewswire.com/news-releases/corteva-agriscience-agriculture-division-of-dowdupont-and-monsanto-reach-licensing-agreement-on-next-generation-corn-insect-control-technology-300649719.html
SOURCE DowDuPont
CHARLOTTE, N.C., April 24, 2018 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today that it is the primary hydroprocessing catalyst manufacturer for the DuPont™ IsoTherming® hydroprocessing technology, making clean fuels production more cost efficient for refiners. IsoTherming® is an innovative hydroprocessing technology that can lower capital and operational costs.
Albemarle and DuPont announce their exclusive collaboration in licensing the IsoTherming® hydroprocessing technology and providing aftermarket products and services.
"We are excited to collaborate with DuPont in supporting the IsoTherming® technology," said Annemie Donkers, VP Clean Fuels Technologies at Albemarle. "We look forward to further development of our IsoTherming® catalyst application know-how with DuPont, to meet our clients' most challenging process conditions."
Eli Ben-Shoshan, Global Business Leader, DuPont Clean Technologies, adds, "Albemarle is a trusted catalyst manufacturer in the industry which is why we pursued a partnership with them. Together, we offer the global refining and mid-stream industries unique IsoTherming® solutions for hydrotreating and mild hydrocracking backed by solid hydroprocessing expertise and cutting-edge innovation."
About Albemarle
Albemarle Corporation (NYSE: ALB), headquartered in Charlotte, NC, is a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts. We power the potential of companies in many of the world's largest and most critical industries, from energy and communications to transportation and electronics. Working side-by-side with our customers, we develop value-added, customized solutions that make them more competitive. Our solutions combine the finest technology and ingredients with the knowledge and know-how of our highly experienced and talented team of operators, scientists and engineers.
Discovering and implementing new and better performance-based sustainable solutions is what motivates all of us. We think beyond business-as-usual to drive innovations that create lasting value. Albemarle employs approximately 5,400 people and serves customers in approximately 100 countries. We regularly post information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, SEC filings and other information regarding our company, its businesses and the markets it serves.
About DuPont Clean Technologies
DuPont Clean Technologies applies real-world experience, history of innovation, problem-solving success and strong brands to help organizations operate safely and with the highest level of performance, reliability, energy efficiency and environmental integrity. The Clean Technologies portfolio includes STRATCO® alkylation technology for production of clean, high-octane gasoline; IsoTherming® hydroprocessing technology for desulfurization of motor fuels; MECS® sulfuric acid production and regeneration technologies; BELCO® air quality control systems for FCC flue gas scrubbing and other refinery scrubbing applications; MECS® DynaWave® technology for sulfur recovery and tail gas-treating solutions; and a comprehensive suite of aftermarket service and solutions offerings. Learn more about DuPont Clean Technologies at www.cleantechnologies.dupont.com.
About DowDuPont Specialty Products Division
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with highly differentiated materials, ingredients and capabilities that help transform industries and everyday life. DowDuPont Specialty Products includes five technology-driven businesses: Electronic Technologies, Industrial Biosciences, Nutrition & Health, Protective Solutions and Sustainable Solutions. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver real-world products and smart solutions across multiple high-value markets. DowDuPont intends to separate the Specialty Products division into an independent, publicly traded company. More information can be found www.dow-dupont.com.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.
View original content with multimedia:http://www.prnewswire.com/news-releases/albemarle-and-dupont-announce-collaboration-in-hydroprocessing-300635612.html
SOURCE Albemarle Corporation
WILMINGTON, Del., Oct. 13, 2017 /PRNewswire/ -- On Oct. 12, 2017, DuPont's board of directors declared regular quarterly dividends of $1.12-1/2 per share on the $4.50 series preferred stock and $0.87-1/2 cents per share on the $3.50 series preferred stock, both payable Jan. 25, 2018, to stockholders of record Jan. 10, 2018.
About DuPont
DuPont, a subsidiary of DowDuPont, has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.
View original content:http://www.prnewswire.com/news-releases/dupont-declares-regular-quarterly-dividend-on-preferred-stock-300536253.html
SOURCE DuPont
MIDLAND, Mich., and WILMINGTON, Del., Sept. 12, 2017 /PRNewswire/ -- DowDuPont™ (NYSE: DWDP) today announced that its Board of Directors and management, with the assistance of independent advisors, have completed their comprehensive review of the portfolio composition of the three intended independent companies. The Board unanimously concluded that, in light of knowledge gained since the announcement of the transaction, certain targeted adjustments will be made between the Materials Science and Specialty Products divisions, which will enhance the competitive advantages of the intended resulting companies. The changes better align these businesses with the end-markets they serve, ensuring clear focus, market visibility, targeted innovation and stronger growth profiles, and better equip each to compete successfully as industry leaders.
The DowDuPont Board of Directors approved the changes based on: a thorough review led by the lead independent directors, which included recommendations provided by McKinsey & Company; a comprehensive business and operational analysis leveraging knowledge gained over the past 20 months of pre-merger planning; and input from a wide range of stakeholders, including both investors and financial advisors. As a result of this comprehensive analysis, DowDuPont will realign the following businesses to the Specialty Products Division from the Materials Science Division:
On a forecasted 2017 basis, the businesses that will be realigned to the Specialty Products Division account for total net sales of more than $8 billion and operating EBITDA of approximately $2.4 billion, including approximately 40 percent of the heritage Dow Corning EBITDA. Relative to the original merger agreement, the adjustments are as follows:
"Our DowDuPont Board is fully aligned and confident that these targeted portfolio adjustments are the right actions to take and will benefit all stakeholders over the long term," said Andrew Liveris, executive chairman of DowDuPont. "They bear out the clear results of a significant comprehensive analysis the Dow and DuPont boards undertook over the past many months, which benefited from a fresh look provided by independent, third-party external advisors, in particular McKinsey & Company. We built on the wealth of knowledge gained as both companies advanced our integration work together. These adjustments are also fully supported by the Materials Science Advisory Committee, as they better align select businesses with the market verticals they serve, while maintaining integration and innovation strengths within strategic value chains. As a result, both our Materials Science and Specialty Products divisions will be well-positioned to better anticipate and meet customer needs through focused innovation and technology development that will deliver accelerated growth from a broader suite of best-in-class products."
"The changes we are making will enhance the competitive advantages and value creation potential of DowDuPont and ensure that the intended companies have the best possible foundation to drive long-term value for all stakeholders," said Ed Breen, chief executive officer of DowDuPont. "The facts clearly supported the strategic logic of this portfolio configuration. Each of the intended companies will have even stronger competitive positioning, high value-added customer solutions, and a distinct and compelling investment thesis, while maximizing opportunities for strategic growth and synergies. With clear focus, each will serve attractive and growing markets, investing in innovation and delivering greater returns for shareholders."
DowDuPont reiterates its previously announced plans to achieve run-rate cost synergies of approximately $3 billion and approximately $1 billion in growth synergies.
Following the portfolio realignments, the three intended companies of DowDuPont are as follows:
The intended company will be headquartered in Wilmington, Delaware, with global business centers in Johnston, Iowa, and Indianapolis, Indiana.
The intended company will maintain the Dow™ brand and will be headquartered in Midland, Michigan.
The intended company will be headquartered in Wilmington, Delaware.
Conference Call
The Company will discuss the results of its review and the path forward during a live webcast call today beginning at 8:30 a.m. ET. Listeners may also join via telephone at +1.719.325.4910. The slide presentation that accompanies the conference call will be posted on the DowDuPont Investor Relations events and presentations page. A replay of the webcast will also be available on the investor events and presentations page of www.dow-dupont.com.
About DowDuPont
DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow Chemical Company and DuPont with the intent to form strong, independent, publicly traded companies in agriculture, materials science and specialty products sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges. For more information, please visit us at www.dow-dupont.com.
Cautionary Statement About Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," similar expressions, and variations or negatives of these words.
On Dec. 11, 2015, The Dow Chemical Company ("Dow") and E. I. du Pont de Nemours and Company ("DuPont") announced entry into an Agreement and Plan of Merger, as amended on March 31, 2017, (the "Merger Agreement") under which the companies would combine in an all-stock merger of equals transaction (the "Merger Transaction"). Effective Aug. 31, 2017, the Merger Transaction was completed and each of Dow and DuPont became subsidiaries of DowDuPont Inc. ("DowDuPont"). For more information, please see each of DowDuPont's, Dow's and DuPont's latest annual, quarterly and current reports on Forms 10-K, 10-Q and 8-K, as the case may be, and the joint proxy statement/prospectus included in the registration statement on Form S-4 filed by DowDuPont with the SEC on March 1, 2016 (File No. 333-209869), as last amended on June 7, 2016, and declared effective by the SEC on June 9, 2016 (the "Registration Statement") in connection with the Merger Transaction.
Forward-looking statements by their nature address matters that are, to different degrees, uncertain, including the intended separation of DowDuPont's agriculture, materials science and specialty products businesses in one or more tax efficient transactions on anticipated terms (the "Intended Business Separations"). Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company's control. Some of the important factors that could cause DowDuPont's, Dow's or DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) successful integration of the respective agriculture, materials science and specialty products businesses of Dow and DuPont, including anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, productivity actions, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the combined operations; (ii) impact of the divestitures required as a condition to consummation of the Merger Transaction as well as other conditional commitments; (iii) achievement of the anticipated synergies by DowDuPont's agriculture, materials science and specialty products businesses; (iv) risks associated with the Intended Business Separations, including those that may result from the comprehensive portfolio review undertaken by the DowDuPont board, changes and timing, including a number of conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including possible issues or delays in obtaining required regulatory approvals or clearances related to the Intended Business Separations, disruptions in the financial markets or other potential barriers; (v) the risk that disruptions from the Intended Business Separations will harm DowDuPont's business (either directly or as conducted by and through Dow or DuPont), including current plans and operations; (vi) the ability to retain and hire key personnel; (vii) potential adverse reactions or changes to business relationships resulting from the completion of the merger or the Intended Business Separations; (viii) uncertainty as to the long-term value of DowDuPont common stock; (ix) continued availability of capital and financing and rating agency actions; (x) legislative, regulatory and economic developments; (xi) potential business uncertainty, including changes to existing business relationships, during the pendency of the Intended Business Separations that could affect the company's financial performance and (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks, as well as other risks associated with the merger and the Intended Business Separations, are more fully discussed in (1) the Registration Statement and (2) the current, periodic and annual reports filed with the SEC by DowDuPont and to the extent incorporated by reference into the Registration Statement, by Dow and DuPont. While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's, Dow's or DuPont's consolidated financial condition, results of operations, credit rating or liquidity. None of DowDuPont, Dow or DuPont assumes any obligation to publicly provide revisions or updates to any forward-looking statements regarding the proposed transaction and intended business separations, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
View original content:http://www.prnewswire.com/news-releases/dowdupont-announces-results-of-comprehensive-portfolio-review-300517691.html
SOURCE DowDuPont
DOW Chemical Freeport Ethylene Cracker (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
DOW European Polyolefins Plant (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
DOW Gulf Coast Polyethylene Unit (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
Dow De-Bottlenecking Project (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
DowDuPont
Dow Low Density Polyethylene Unit (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
DowDuPont
Dow NORDEL Metallocene EPDM Unit (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
DowDuPont
Dow Polyolefin Elastomer Unit (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
DowDuPont
Dow Saudi Ariabian Silicones Facility (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
ELITE Polyethylene Production Unit (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
DowDuPont
Fort Saskatchewan Etyhlene Expansion (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
Fort Saskatchewan Zero-Carbon Ethylene Cracker and Derivatives Project (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
Freeport Ethylene Cracker Expansion (TX-9) (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
Plaschem Park Polymer Facility (subscriber access)
Status: (subscriber access)
Parent Entities:
Dow Inc.
Sabine River Works Ethylene Expansion (subscriber access)
Status: (subscriber access)
Parent Entities:
Dupont
Subscribe now for access to Criterion Research's historical production and forecast production by company.
Subscribe now for access to Criterion Research's hedge and analysis.